Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 4517971, 92 pages
https://doi.org/10.1155/2017/4517971
Review Article

Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases

Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown 2193, South Africa

Correspondence should be addressed to Sandy van Vuuren

Received 21 July 2016; Accepted 9 October 2016; Published 4 May 2017

Academic Editor: Pinarosa Avato

Copyright © 2017 Ané Orchard and Sandy van Vuuren. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Essential oils are one of the most notorious natural products used for medical purposes. Combined with their popular use in dermatology, their availability, and the development of antimicrobial resistance, commercial essential oils are often an option for therapy. At least 90 essential oils can be identified as being recommended for dermatological use, with at least 1500 combinations. This review explores the fundamental knowledge available on the antimicrobial properties against pathogens responsible for dermatological infections and compares the scientific evidence to what is recommended for use in common layman’s literature. Also included is a review of combinations with other essential oils and antimicrobials. The minimum inhibitory concentration dilution method is the preferred means of determining antimicrobial activity. While dermatological skin pathogens such as Staphylococcus aureus have been well studied, other pathogens such as Streptococcus pyogenes, Propionibacterium acnes, Haemophilus influenzae, and Brevibacterium species have been sorely neglected. Combination studies incorporating oil blends, as well as interactions with conventional antimicrobials, have shown that mostly synergy is reported. Very few viral studies of relevance to the skin have been made. Encouragement is made for further research into essential oil combinations with other essential oils, antimicrobials, and carrier oils.

1. Introduction

The skin is the body’s largest mechanical barrier against the external environment and invasion by microorganisms. It is responsible for numerous functions such as heat regulation and protecting the underlying organs and tissue [1, 2]. The uppermost epidermal layer is covered by a protective keratinous surface which allows for the removal of microorganisms via sloughing off of keratinocytes and acidic sebaceous secretions. This produces a hostile environment for microorganisms. In addition to these defences, the skin also consists of natural microflora which offers additional protection by competitively inhibiting pathogenic bacterial growth by competing for nutrients and attachment sites and by producing metabolic products that inhibit microbial growth. The skin’s natural microflora includes species of Corynebacterium, staphylococci, streptococci, Brevibacterium, and Candida as well as Propionibacterium [38].

In the event of skin trauma from injuries such as burns, skin thinning, ulcers, scratches, skin defects, trauma, or wounds, the skin’s defence may be compromised, allowing for microbial invasion of the epidermis resulting in anything from mild to serious infections of the skin. Common skin infections caused by microorganisms include carbuncles, furuncles, cellulitis, impetigo, boils (Staphylococcus aureus), folliculitis (S. aureus, Pseudomonas aeruginosa), ringworm (Microsporum spp., Epidermophyton spp., and Trichophyton spp.), acne (P. acnes), and foot odour (Brevibacterium spp.) [3, 811]. Environmental exposure, for example, in hospitals where nosocomial infections are prominent and invasive procedures make the patient vulnerable, may also create an opportunity for microbial infection. For example, with the addition of intensive therapy and intravascular cannulae, S. epidermidis can enter the cannula and behave as a pathogen causing bloodborne infections. Noninfective skin diseases such as eczema can also result in pathogenic infections by damaging the skin, thus increasing the risk of secondary infection by herpes simplex virus and/or S. aureus [5, 8, 12].

Skin infections constitute one of the five most common reasons for people to seek medical intervention and are considered the most frequently encountered of all infections. At least six million people worldwide are affected by chronic wounds and up to 17% of clinical visits are a result of bacterial skin infections and these wounds are a frequent diagnosis for hospitalised patients. These are experienced daily and every doctor will probably diagnose at least one case per patient. Furthermore, skin diseases are a major cause of death and morbidity [8, 13, 14]. The healing rate of chronic wounds is affected by bacterial infections (such as S. aureus, E. coli, and P. aeruginosa), pain, inflammation, and blood flow, and thus infection and inflammation control may assist in accelerating healing [1517].

Topical skin infections typically require topical treatment; however, due to the ability of microbes to evolve and due to the overuse and incorrect prescribing of the current available conventional antimicrobials, there has been emergence of resistance in common skin pathogens such as S. aureus resulting as methicillin-resistant Staphylococcus aureus (MRSA) and other such strains. Treatment has therefore become a challenge and is often not successful [8, 18, 19]. In some regions of the world, infections are unresponsive to all known antibiotics [20]. This threat has become so severe that simple ulcers now require treatment with systemic antibiotics [21]. A simple cut on the finger or a simple removal of an appendix could result in death by infection. The World Health Organization (WHO) has warned that common infections may be left without a cure as we are headed for a future without antibiotics [22]. Therefore, one of the solutions available is to make use of one of the oldest forms of medicine, natural products, to treat skin infections and wounds [18, 23].

Complementary and alternative medicines (CAMs) are used by 60–80% of developing countries as they are one of the most prevalent sources of medicine worldwide [2427]. Essential oils are also one of the most popular natural products, with one of their main applications being for their use in dermatology [2830]. In fact, of all CAMs, essential oils are the most popular choice for treating fungal skin infections [13, 31]. Their use in dermatology, in the nursing profession, and in hospitals has been growing with great popularity worldwide, especially in the United States and the United Kingdom [1, 27, 3235]. Furthermore, the aromatherapeutic literature [1, 2, 26, 32, 3643] identifies numerous essential oils for dermatological use, the majority of which are recommended for infections. This brought forth the question as to the efficacy of commercial essential oils against the pathogens responsible for infections. The aim of this review was to collect and summarise the in vivo, in vitro, and clinical findings of commercial essential oils that have been tested against infectious skin diseases and their pathogens and, in doing so, offer aromatherapists and dermatologists valuable information regarding the effectiveness of essential oils for dermatological infections.

The readily available aromatherapeutic literature has reported over 90 (Table 1) commercial essential oils that may be used for treating dermatological conditions [1, 2, 26, 32, 3643]. An overview of the skin related uses can be seen in Figure 1. Essential oils are mostly used for the treatment of infections caused by bacteria, fungi, or viruses (total 62%). This is followed by inflammatory skin conditions (20%) such as dermatitis, eczema, and lupus and then general skin maintenance (18%) such as wrinkles, scars, and scabs, which are the third most common use of essential oils. Other applications include anti-inflammatory and wound healing applications (Figure 1). Of the 98 essential oils recommended for dermatological use, 88 are endorsed for treating skin infections. Of these, 73 are used for bacterial infections, 49 specifically for acne, 34 for fungal infections, and 16 for viral infections.

Table 1: Essential oils used in dermatology.
Figure 1: Summary of categorised dermatological conditions in which essential oils are used.

2. Materials and Methods

2.1. Searching Strategy/Selection of Papers

The aim of the comparative review was to identify the acclaimed dermatological commercial essential oils according to the aromatherapeutic literature and then compare and analyse the available published literature. This will serve as a guideline in selecting appropriate essential oils in treating dermatological infections. The analysed papers were selected from three different electronic databases: PubMed, ScienceDirect, and Scopus, accessed during the period 2014–2016. The filters used included either “essential oils”, “volatile oils”, or “aromatherapy” or the scientific or common name for each individual essential oil listed in Table 1 and the additional filters “antimicrobial”, “antibacterial”, “skin”, “infection”, “dermatology”, “acne”, “combinations”, “fungal infections”, “dermatophytes”, “Brevibacteria”, “odour”, “antiviral”, “wounds”, “dermatitis”, “allergy”, “toxicity”, “sentitisation”, or “phototoxicity”.

2.2. Inclusion Criteria

In order to effectively understand the possible implications and potential of essential oils, the inclusion criteria were broad, especially with this being the first review to collate this amount of scientific evidence with the aromatherapeutic literature. Inclusion criteria included the following:(i)Type of in vitro studies for bacterial and fungal pathogens by means of the microdilution assay, macrodilution assay, or the agar dilution assay(ii)In vivo studies(iii)Antiviral studies(iv)Case reports(v)Animal studies(vi)All clinical trials

2.3. Exclusion Criteria

Papers or pieces of information were excluded for the following reasons:(i)Lack of accessibility to the publication(ii)If the incorrect in vitro technique (diffusion assays) was employed(iii)Indigenous essential oils with no relevance to commercial oils(iv)If they were in a language not understood by the authors of the review(v)Pathogens studied not relevant to skin disease

2.4. Data Analysis

The two authors (Ané Orchard and Sandy van Vuuren) conducted their own data extraction independently, after which critical analysis was applied. Information was extrapolated and recorded and comments were made. Observations were made and new recommendations were made as to future studies.

3. Results

3.1. Description of Studies

After the initial database search, 1113 reports were screened. Duplicates were removed, which brought the article count down to 513, after which the abstracts were then read and additional reports removed based on not meeting the inclusion criteria. A final number of 349 articles were read and reviewed. Of these, 143 were in vitro bacterial and fungal studies (individual oil and 45 combinations), two in vivo studies, 15 antiviral studies, 19 clinical trials, and 32 toxicity studies. The process that was followed is summarised in Figure 2.

Figure 2: Flow diagram of the review approach.
3.2. Experimental Approaches
3.2.1. Chemical Analysis

Essential oils are complex organic (carbon containing) chemical entities, which are generally made up of hundreds of organic chemical compounds in combination that are responsible for the essential oil’s many characteristic properties. These characteristics may include medicinal properties, such as anti-inflammatory, healing, or antimicrobial activities, but may also be responsible for negative qualities such as photosensitivity and toxicity [37].

Even with the high quality grade that is strived for in the commercial sector of essential oil production, it must be noted that it is still possible for essential oil quality to display discrepancies, changes in composition, or degradation. The essential oil composition may even vary between the same species [1, 44]. This may be due to a host of different factors such as the environment or location that the plants are grown in, the harvest season, which part of the plant was used, the process of extracting the essential oil, light or oxygen exposure, the storage of the oil, and the temperature the oil was exposed to [4551].

Gas chromatography in combination with mass spectrometry (GCMS) is the preferred technique for analysis of essential oils [52]. This is a qualitative and quantitative chemical analysis method which allows for the assurance of the essential oil quality through the identification of individual compounds that make up an essential oil [1, 45, 53]. It has clearly been demonstrated that there is a strong correlation between the chemical composition and antimicrobial activity [51, 54, 55]. Understanding the chemistry of essential oils is essential for monitoring essential oil composition, which then further allows for a better understanding of the biological properties of essential oils. It is recommended to always include the chemical composition in antimicrobial studies [56].

3.3. Antimicrobial Investigations

Several methods exist that may be employed for antimicrobial analysis, with two of the most popular methods being the diffusion and the dilution methods [5659].

3.3.1. Diffusion Method

There are two types of diffusion assays. Due to the ease of application, the disc diffusion method is one of the most commonly used methods [60]. This is done by applying a known concentration of essential oil onto a sterile filter paper disc. This is then placed onto agar which has previously been inoculated with the microorganism to be tested, or it is spread on the surface. If necessary, the essential oil may also be dissolved in an appropriate solvent. The other diffusion method is the agar diffusion method, where, instead of discs being placed, wells are made in the agar into which the essential oil is instilled. After incubation, antimicrobial activity is then interpreted from the zone of inhibition (measured in millimetres) using the following criteria: weak activity (inhibition zone ≤ 12 mm), moderate activity (12 mm < inhibition zone < 20 mm), and strong activity (inhibition zone ≤ 20 mm) [24, 6062].

Although this used to be a popular method, it is more suitable to antibiotics rather than essential oils as it does not account for the volatile nature of the essential oils. Essential oils also diffuse poorly through an aqueous medium as they are hydrophobic. Thus, the results are less reliable as they are influenced by the ability of the essential oil to diffuse through the agar medium, resulting in variable results, false negatives, or a reduction in antimicrobial activity [24, 63]. The results have been found to vary significantly when tested this way and are also influenced by other factors such as disc size, amount of compound applied to the disc, type of agar, and the volume of agar [57, 59, 6468]. It has thus been recommended that results are only considered where the minimum inhibitory concentration (MIC) or cidal concentration values have been established [65].

3.3.2. Dilution Methods

The dilution assays are reliable, widely accepted, and promising methods for determining an organism’s susceptibility to inhibitors. The microdilution method is considered the “gold standard” [64, 6870]. This is a quantitative method that makes it possible to calculate the MIC and allows one to understand the potency of the essential oil [68, 71]. With one of the most problematic characteristics of essential oils being their volatility, the microdilution technique allows for an opportunity to work around this problem as it allows for less evaporation due to the essential oil being mixed into the broth [67].

This microdilution method makes use of a 96-well microtitre plate under aseptic conditions where the essential oils (diluted in a solvent to a known concentration) are serially diluted. Results are usually read visually with the aid of an indicator dye. The microdilution results can also be interpreted by reading the optical density [72, 73]; however, the shortcoming of this method is that the coloured nature of some oils may interfere with accurate turbidimetric readings [74].

Activity is often classified differently according to the quantitative method followed. van Vuuren [56] recommended 2.00 mg/mL and less for essential oils to be considered as noteworthy, Agarwal et al. [75] regarded 1.00% and less, and Hadad et al. [76] recommended ≤250.00 μg/mL. On considering the collection of data and frequency of certain MIC values, this review recommends MIC values of ≤1.00 mg/mL as noteworthy.

The macrodilution method employs a similar method to that of the microdilution method, except that, instead of a 96-well microtitre plate being used, multiple individual test tubes are used. Although the results are still comparable, this is a time-consuming and a tedious method, whereas the 96-well microtitre plate allows for multiple samples to be tested per plate, allowing for speed, and it makes use of smaller volumes which adds to the ease of its application [77, 78]. The agar dilution method is where the essential oil is serially diluted, using a solvent, into a known amount of sterile molten agar in bottles or tubes and mixed with the aid of a solvent. The inoculum is then added and then the agar is poured into plates for each dilution and then incubated. The absence of growth after incubation is taken as the MIC [7981].

3.3.3. The Time-Kill Method

The time-kill (or death kinetic) method is a labour intensive assay used to determine the relationship between the concentration of the antimicrobial and the bactericidal activity [82]. It allows for the presentation of a direct relationship in exposure of the pathogen to the antimicrobial and allows for the monitoring of a cidal effect over time [74]. The selected pathogen is exposed to the antimicrobial agent at selected time intervals and aliquots are then sampled and serially diluted. These dilutions are then plated out onto agar and incubated at the required incubation conditions for the pathogen. After incubation, the colony forming units (CFU) are counted. These results are interpreted from a logarithmic plot of the amount of remaining viable cells against time [74, 82, 83]. This is a time-consuming method; however, it is very useful for deriving real-time exposure data.

3.4. Summary of Methods

The variation in essential oil test methods makes it difficult to directly compare results [24, 58]. Numerous studies were found to employ the use of a diffusion method due to its acclaimed “ease” and “time saving” ability of the application. Researchers tend to use this as a screening tool whereby results displaying interesting outcomes are further tested using the microdilution method [8487]. The shortcoming of this method is that firstly, due to the discussed factors affecting the diffusion methods, certain essential oils demonstrate no inhibition against the pathogen, and thus further studies with the oils are overlooked. Secondly, the active oils are then investigated further using the microdilution method. Therefore, the researchers have now doubled the amount of time required to interpret the quantitative data. Thirdly, the method may be believed to be a faster method if one considers the application; however, if one considers the preparation of the agar plates and their risk of contamination as well as the overall process of this method, there is very little saving of time and effort.

It is recommended to follow the correct guidelines as set out by the Clinical and Laboratory Standards Institute M38-A (CLSI) protocol [88] and the standard method proposed by the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing (AFST-EUCAST) [89] for testing with bacteria and filamentous fungi.

Other factors that may affect results and thus make it difficult to compare published pharmacological results of essential oils are where data is not given on the chemical composition, the microbial strain number, temperature and length of incubation, inoculum size, and the solvent used. The use of appropriate solvents helps address the factor of poor solubility of essential oils. Examples include Tween, acetone, dimethylformamide (DMF), dimethylsulfoxide (DMSO), and ethanol. Tween, ethanol, and DMSO have, however, been shown to enhance antimicrobial activity of essential oils [24, 53, 90]. Soković et al. [91] tested antimicrobial activity with ethanol as the solvent and Tween. When the essential oils were diluted with Tween, it resulted in a greater antifungal activity; however, Tween itself does not display its own antimicrobial activity [92]. Eloff [93] identified acetone as the most favourable solvent for natural product antimicrobial studies.

The inoculum is a representative of the microorganisms present at the site of infection [94]. When comparing different articles, the bacterial inoculum load ranges from to  CFU/mL. The antibacterial activity is affected by inoculum size [62, 9599]. If this concentration is too weak, the effect of the essential oils strengthens; however, this does not allow for a good representation of the essential oil’s activity. If the inoculum is too dense, the effect of the essential oil weakens and the inoculum becomes more prone to cross contamination [100]. Future studies should aim to keep the inoculum size at the recommended  CFU/mL [99].

4. Pathogenesis of Wounds and Skin Infections and the Use of Essential Oils

The pathogenesis of the different infections that are frequently encountered in wounds and skin infections is presented in Table 2. A more in-depth analysis of essential oils and their use against these dermatological pathogens follows.

Table 2: Pathogens responsible for infectious skin diseases.
4.1. Gram-Positive Bacteria

The Gram-positive bacterial cell wall is comprised of a 90–95% peptidoglycan layer that allows for easy penetration of lipophilic molecules into the cells. This thick lipophilic cell wall also results in essential oils making direct contact with the phospholipid bilayer of the cell membrane which allows for a physiological response to occur on the cell wall and in the cytoplasm [183, 184].

4.1.1. Staphylococcus aureus

Staphylococcus aureus is a common Gram-positive bacterium that can cause anything from local skin infections to fatal deep tissue infections. The pathogen is also found colonising acne and burn wounds [185187]. Methicillin-resistant S. aureus (MRSA) is one of the most well-known and widespread “superbugs” and is resistant to numerous antibiotics [158]. Methicillin-resistant S. aureus strains can be found to colonise the skin and wounds of over 63%–90% of patients and have been especially infamous as being the dreaded scourge of hospitals for several years [22, 188190]. Staphylococcus aureus has developed resistance against erythromycin, quinolones, mupirocin, tetracycline, and vancomycin [190192].

Table 3 shows some of the antimicrobial in vitro studies undertaken on commercial essential oils and additional subtypes against this most notorious infectious agent of wounds. Of the 98 available commercial essential oils documented from the aromatherapeutic literature for use for dermatological infections, only 54 oils have been tested against S. aureus and even fewer against the resistant S. aureus strain. This is troubling, especially if one considers the regularity of S. aureus resistance. It should be recommended that resistant S. aureus strains always be included with every study.

Table 3: Essential oil studies against S. aureus.

When considering the antimicrobial activity of the tested essential oils, it can be noted how the main compounds influence overall antimicrobial activity. Melaleuca alternifolia (tea tree), rich in terpinen-4-ol, showed noteworthy activity, and Anthemis aciphylla var. discoidea (chamomile) containing α-pinene and terpinen-4-ol displayed noteworthy activity (1.00 mg/mL) [114], whereas the essential oil predominantly containing terpinen-4-ol displayed an MIC value of 0.50 mg/mL. The Origanum spp. (Origanum scabrum and Origanum vulgare) were shown to display rather impressive antimicrobial activity, which appeared to predominantly be related to the amount of carvacrol [163]. Geraniol also appears to be a compound that influences antimicrobial activity against the staphylococci spp. as can be seen for Backhousia citriodora (lemon myrtle) and Cymbopogon martinii (palmarosa) (geraniol 61.6%) [125, 126]. Cymbopogon martinii, with lower levels of geranial (44.80%), showed moderate antimicrobial activity [99]. Mentha piperita (peppermint) had higher antimicrobial activity for oils with higher concentrations of menthol [128, 155]. Laurus nobilis (bay), Styrax benzoin, and Cinnamomum zeylanicum (cinnamon), each rich in eugenol, were found to have notable activity [99].

It is interesting to consider the essential oils investigated and to compare them to what is recommended in the aromatherapeutic literature. For example, Lavandula angustifolia (lavender) is recommended for abscesses, carbuncles, and wounds [2, 26, 32, 3643], which all involve S. aureus; however, in vitro activity was found to discount this oil as an antimicrobial [99, 136, 139, 140]. The same could be said about essential oils such as Achillea millefolium (yarrow) [112], Anthemis nobilis (Roman chamomile) [99], Boswellia carteri (frankincense) [116], Citrus aurantifolia (lime) [80], Foeniculum vulgare (fennel) [132, 133], and Melissa officinalis (lemon balm) [139].

Some clinical studies included the evaluation of the effects of essential oils on malodorous necrotic ulcers of cancer patients. The use of an essential oil combination (mostly containing Eucalyptus globulus (eucalyptus)) resulted in a decrease in inflammation, reduction of the odour, and improved healing rates [193]. Edwards-Jones et al. [194] performed a clinical study with a wound dressing containing essential oils to decrease infection risk. Ames [195] found Melaleuca alternifolia (tea tree) to be effective in treating wounds; and Matricaria recutita (German chamomile) with L. angustifolia at a 50 : 50 ratio diluted in calendula oil was found to improve leg ulcers and pressure sores.

Methicillin-resistant S. aureus hinders the rate of wound healing, which may lead to chronic wounds [196]. Delayed wound healing has been proven to lead to psychological stress and social isolation [197, 198]. A randomised controlled trial, consisting of 32 patients (16 in control group, 16 in placebo group) with stage II and above MRSA-colonised wounds that were not responding to treatment, was undertaken where the control group was treated with a 10% topical M. alternifolia preparation and was found to effectively decrease colonising MRSA in 87.5% of patients and result in a 100% healing rate within 28 days [196]. These studies lead to the high recommendation of the incorporation of this essential oil combination in palliative care.

Methicillin-resistant S. aureus may potentially be carried and propagated by hospital staff and patients, which is an acknowledged risk for hospital-acquired infections [147, 189]. Therefore, successful decolonisation of MRSA from patients and good hygiene may improve the microbial load, number of reinfections, and ultimately therapeutic outcomes of patients [199]. A topical preparation containing M. alternifolia essential oil has been considered for assistance in eradicating MRSA in hospitals, due to its reported efficacy [200]. The largest randomised trial against MRSA colonisation included 224 patients where the control group was treated with 2% nasal mupirocin applied three times a day, 4% chlorhexidine gluconate soap used at least once a day, and 1% silver sulfadiazine cream applied to skin infections once a day. The study group was treated with 10% M. alternifolia oil nasal cream applied three times a day and 5% M. alternifolia oil body wash used at least once daily with a 10% M. alternifolia cream applied to skin infections. The results showed that 41% of patients in the study group were cleared as opposed to 49% of patients on the standard therapy [200]. A small three-day pilot study was designed by Caelli et al. [189] to observe whether daily washing with a 5% M. alternifolia oil would clear MRSA colonisation which may result in ICU patient outcome improvement [199]. The test group made use of 4% M. alternifolia nasal ointment and 5% M. alternifolia oil body wash and was compared to a conventional treatment consisting of 2% mupirocin nasal ointment and triclosan body wash. The test group overall was found to have more improvement at the infection site when compared to the control group. Although the pilot study was too small to be statistically significant, the researchers did find that the M. alternifolia oil performed better than the conventional treatment and was effective, nontoxic, and well tolerated [189]. Messager et al. [90] tested 5% M. alternifolia ex vivo in a formulation, where it again was proven to decrease the pathogenic bacteria on the skin. In another study, M. alternifolia oil was investigated to determine the influence on healing rates [201]. The patients were treated with water-miscible tea tree oil (3.30%) solution applied as part of the wound cleansing regimen. This study used this oil as a wash only three times a week which is not how this oil is prescribed and hence the results were not positive. A more accurate method of study was shown by Chin and Cordell [202], where M. alternifolia oil was used in a dressing for wound healing abilities. All patients, except for one, were found to have an accelerated healing rate of abscessed wounds and cellulitis. The concluding evidence shows that there is definitely potential for the use of M. alternifolia (tea tree) oil as an additional/alternative treatment to standard wound treatments [203].

The healing potential of Commiphora guidotti (myrrh) was investigated via excisions of rats. The authors could confidently report on an increased rate in wound contraction and candid wound healing activity that was attributed to the antimicrobial and anti-inflammatory effects of this oil [204]. Ocimum gratissimum (basil) was also found by Orafidiya et al. [205] to promote wound healing by eradicating the infectious pathogens and by inducing early epithelialisation and moderate clotting formation, thereby accelerating scab formation, contraction, and granulation.

From these studies, clearly, M. alternifolia has shown great promise against S. aureus. However, considering the potential of essential oils in clinical practice and comparing them to essential oils with promising in vitro activity, other oils such as Cymbopogon citratus (lemongrass), Santalum album (sandalwood), and Vetiveria zizanioides/Andropogon muricatus (vetiver) should in the future be paid the same amount of attention.

4.1.2. Pathogens Involved in Acne

Pathogens associated with acne include Propionibacterium acnes, Propionibacterium granulosum, and Staphylococcus epidermidis [206208]. Methicillin-resistant S. epidermidis (MRSE) have become extensively problematic microorganisms in the recent years due to their antimicrobial resistance and P. acnes has developed resistance to tetracycline, erythromycin, and clindamycin. Both have also shown multidrug resistance, including against quinolones [158, 188, 206]. Table 4 displays the in vitro antimicrobial efficacies of commercial essential oils against bacteria involved in the pathogenesis of acne. When observing the number of commercial essential oils that are recommended for acne treatment, less than half of the commercial oils have actually focused on S. epidermidis, P. granulosum, and P. acnes. Overall, the acne pathogens have been sorely neglected in essential oil studies.

Table 4: Antimicrobial efficacy of essential oils against pathogens associated with acne.

For Anthemis aciphylla var. discoidea (chamomile) 0.13–0.25 mg/mL, initially, it appeared that higher α-pinene and lower terpinen-4-ol showed higher antimicrobial activity. However, the sample with terpinen-4-ol predominantly as its main component displayed the best activity at 0.06 mg/mL. This makes α-pinene appear as an antimicrobial antagonist. Cinnamomum zeylanicum, Rosa centifolia (rose), L. angustifolia, and Syzygium aromaticum (clove) displayed noteworthy antimicrobial activity against both S. epidermidis and P. acnes. Only the latter two are, however, recommended in the aromatherapeutic literature for the treatment of acne. Leptospermum scoparium (manuka) showed noteworthy activity for both P. acnes and S. epidermidis; however, Tween 80 was used as a solvent, which may overexaggerate the antimicrobial activity. Another study also found L. scoparium to effectively inhibit P. acnes. As was seen against S. aureus, O. scabrum and O. vulgare also notably inhibited S. epidermidis. Unfortunately, these oils were not studied against P. acnes. Cymbopogon citratus was shown to effectively inhibit P. acnes; however, no data was available against S. epidermidis. Essential oils such as S. album, V. zizanioides, Viola odorata (violet), Citrus aurantium var. amara (petitgrain), and Citrus bergamia (bergamot) are a few that are recommended for the treatment of acne and other microbial infections [2, 26, 32, 36, 37, 4043] in the aromatherapeutic literature that are yet to be investigated.

Some clinical studies have shown promising results. A four-week trial comparing O. gratissimum oil with 10% benzoyl peroxide and a placebo was conducted and was aimed at reducing acne lesions in students. The 2% and 5% O. gratissimum oils in the hydrophilic cetomacrogol base were found to reduce acne lesions faster than standard therapy, and they were well tolerated. The 5% preparation, despite being highly effective, caused skin irritation. Overall, O. gratissimum oil showed excellent potential in the management of acne as it was as effective as benzoyl peroxide, although it was less popular with patients due to the unpleasant odour [217].

Melaleuca alternifolia oil demonstrated in vitro antimicrobial and anti-inflammatory activity against P. acnes and S. epidermidis and is in fact the essential oil on which most clinical trials have been undertaken. Bassett et al. [218] performed one of the first rigorous single-blinded randomised (RCT) controlled trials consisting of 124 patients that assessed the efficacy of 5% M. alternifolia gel in comparison to 5% benzoyl peroxide lotion in the management of mild to moderate acne. Both treatments showed equal improvement in the acne lesions. Enshaieh et al. [219] evaluated the efficacy of 5% M. alternifolia on mild to moderate acne vulgaris. The 5% M. alternifolia oil was found to be effective in improving the number of papules in both inflammatory and noninflammatory acne lesions and was found to be more effective than the placebo. Proven efficacy has made M. alternifolia preparations popular in acne products.

Other oil studies included a gel formulation containing acetic acid, Citrus sinensis (orange), and Ocimum basilicum (sweet basil) essential oils, which was tested in acne patients. The combination of these antimicrobial essential oils and the keratolytic agent resulted in a 75% improvement in the rate of acne lesion healing [220].

If one examines the results displayed in Table 4, essential oils such as Anthemis aciphylla var. discoidea (chamomile), C. zeylanicum, Citrus aurantium (bitter orange), O. vulgare (oregano), and S. aromaticum displayed higher antimicrobial activity in vitro than M. alternifolia, yet these essential oils have to be investigated clinically.

4.1.3. Gram-Negative Bacteria

The Gram-negative bacterial cell wall consists of a 2-3 nm thick peptidoglycan layer (thinner than Gram-positive bacteria), which means that the cell wall consists of a very small percentage of the bacteria. The cell wall is further surrounded by an outer membrane (OM) which is comprised of a double layer of phospholipids that are linked to an inner membrane by lipopolysaccharides (LPS). This OM protects the bacteria from lipophilic particles; however, it makes them more vulnerable to hydrophilic solutes due to the abundance of porin proteins that serve as hydrophilic transmembrane channels [184, 221, 222].

Gram-negative pathogens present a serious threat with regard to drug resistance, especially Escherichia coli and Pseudomonas aeruginosa [190, 192]. These pathogens that are found to colonise wounds often cause multidrug resistance [166, 223]. β-Lactamase-positive E. coli is appearing frequently among nonhospital patients [224]. Pseudomonas aeruginosa is a regular cause of opportunistic nosocomial infections [187]. It is often involved in localised skin infections, green nail syndrome, and interdigital infection, colonises burn wounds, and may expand into a life-threatening systemic illness [225].

A number of essential oils display antimicrobial activity against E. coli and P. aeruginosa with the predominant studies having been done against E. coli (Table 5). The Gram-negative pathogens appear to be a lot more resistant to essential oil inhibition than the Gram-positive bacteria, but this a known fact.

Table 5: Essential oil studies showing efficacy against Gram-negative pathogens associated with skin infections.

Aniba rosaeodora (rosewood) was found to inhibit E. coli at an MIC value of 0.40 mg/mL. No GC-MS data was given [85]. Anthemis aciphylla var. discoidea (chamomile) also displayed notable inhibition against E. coli and P. aeruginosa; however, the highest activity was seen for the essential oil containing high levels of α-pinene (39.00%) and terpinen-4-ol (32.10%) [114]. Cinnamomum zeylanicum, with the main compound cinnamaldehyde, was shown to have inhibited these two Gram-negative pathogens at noteworthy MIC values [80]. Noteworthy activity was also reported for Commiphora myrrha (myrrh) and Thymus numidicus (thyme) [99]. Syzygium aromaticum and S. album were reported to effectively inhibit P. aeruginosa [99]; and Thymus vulgaris (thyme) inhibits E. coli (including multidrug-resistant strains) [182].

4.1.4. Other Bacterial Pathogens

Brevibacterium spp. form part of the Coryneform bacteria and are involved in foul body odour [3, 103]. Insufficient quantitative studies have been conducted using commercial essential oils to treat problems caused by these microorganisms, even though there have been some earlier studies using the diffusion assays against B. linen [226228]. One quantitative study reported on the activity of Ziziphora persica against B. agri (125 μg/mL) and B. brevis (250 μg/mL), in addition to Ziziphora clinopodioides against B. agri (31.25 μg/mL) and B. brevis (125 μg/mL) [229]. In another study, essential oils of Kunzea ericoides (Kānuka) and L. scoparium were able to inhibit three species of Brevibacterium (MIC: 0.06–1.00 mg/mL) [138]. Clearly, the lack of attention to this neglected group of microorganisms warrants further attention, especially considering that, to the best of our knowledge, not one essential oil recommended for odour has been investigated against relevant pathogens in vitro.

The β-hemolytic Streptococcus (S. pyogenes) is a threatening pathogen that needs to be considered when investigating wound infections [166]. Group A Streptococcus (GAS) is usually involved in impetigo and necrotising fasciitis (“flesh-eating” disease). This pathogen has developed resistance to erythromycin, azithromycin, clarithromycin, clindamycin, and tetracycline [188, 190]. Group B Streptococcus is also involved in skin infections and has developed resistance to clindamycin, erythromycin, azithromycin, and vancomycin [190]. Periorbital cellulitis is a common occurrence in children and is caused by Haemophilus influenzae [106], and Clostridium spp. (C. perfringens, C. septicum, C. tertium, C. oedematiens, and C. histolyticum) are involved in gas green/gangrene infections. Table 6 summarises the antimicrobial activity of essential oils that have been studied and shown to have some in vitro efficacy against these pathogens. The lack of studies against S. pyogenes, C. perfringens, and H. influenza highlights the need to investigate these sorely neglected dermatologically important pathogens, especially since the few available studies have shown these organisms to be highly susceptible to essential oil inhibition. These are also pathogens that cause deeper skin infections, so, with the enhanced penetration offered by essential oils, they may prove beneficial.

Table 6: Essential oil studies showing efficacy against other bacterial skin pathogens.
4.1.5. Fungal Infections: Yeasts

Yeasts may act as opportunistic pathogens and can result in infection if presented with the opportunity, the most common pathogen being Candida albicans. Candida spp. can cause candidiasis at several different anatomical sites [230]. Candida has started developing resistance to first-line and second-line antifungal treatment agents such as fluconazole [190]. Essential oils demonstrating noteworthy activity against this organism are shown in Table 7. Candida albicans has been quite extensively investigated and most oils used in dermatology have been tested against this pathogen.

Table 7: Essential oils demonstrating noteworthy antimicrobial efficacy against C. albicans.

Cymbopogon citratus, C. martinii, L. nobilis, M. piperita, P. graveolens, Santolina chamaecyparissus (santolina), and Thymus spp. are essential oils recommended in the aromatherapeutic literature for the treatment of fungal infections that have in vitro evidence confirming the effectiveness as antifungals. Cananga odorata (ylang-ylang), Cinnamomum cassia (cinnamon), C. zeylanicum, Coriandrum sativum (coriander), Cymbopogon nardus (citronella), Matricaria chamomilla (German chamomile), and S. benzoin also displayed in vitro noteworthy activity; however, these are interestingly not recommended in the aromatherapeutic literature.

In an in vivo study, L. angustifolia was found to effectively inhibit growth of C. albicans isolated from 20 patients, which was comparative to the inhibition observed by clotrimazole [272].

4.1.6. Fungal Infections: Dermatophytes

Infection with these organisms results in dermatophytosis, which affects the skin, nails, or hair [230, 273, 274]. There is a 10–20% risk of a person acquiring a dermatophyte infection [29], and although the symptoms do not necessarily pose a threat, the treatment is costly and onerous due to resistance and side effects [29]. Essential oils present an excellent option for treating superficial human fungal infections, especially when one is confronted with the effective antifungal results found in previous studies (Table 8). This is encouraging considering the difficulty and challenges faced in treating these infections.

Table 8: Essential oils against dermatophytes and other yeasts.

The ability of topical formulations to penetrate the skin is crucial for the effective treatment of subcutaneous infections [108]. Melaleuca alternifolia oil has displayed in vitro activity against M. mycetomatis and M. furfur, proving its potential in treating eumycetoma, pityriasis, and seborrheic dermatitis, not only because of its antifungal activity, but also because of its ability to penetrate the skin due to its main compound (terpinen-4-ol) [108, 109, 275, 276].

Onychomycosis is generally resilient to topical treatment of any kind; thus, there is a poor cure rate. It is usually treated systemically due to its infrequency in responding to topical treatments [277, 278]. With onychomycosis being the most frequent cause of nail disease, Buck et al. [279] aimed to treat onychomycosis in clinical trials whereby 60% of patients were treated with M. alternifolia oil and 61% of patients were treated with 1% clotrimazole. There was only a 1% difference between the two study groups. What would be interesting for future studies is to determine what the results would be when testing the same treatments against resistant strains.

Tinea pedis is often treated topically, which presents an opportunity for essential oil use [280]. Melaleuca alternifolia oil was evaluated in two trials for treating tinea pedis. In the first trial by Tong et al. [281], the patients were treated with either a 10% M. alternifolia oil in sorbolene, 1% tolnaftate, or a placebo (sorbolene). The patients on M. alternifolia oil treatment had a mycological cure rate of 30%. Mycological cure rates of 21% were seen in the placebo group and of 85% in patients receiving tolnaftate, proving the essential oil to not be as effective. The second trial tested two solutions of 25% and 50% M. alternifolia oil in ethanol and polyethylene glycol. This was compared to a placebo containing only the vehicle in a double-blinded randomised controlled trial [282]. The placebo group showed a clinical response in 39% of patients. Melaleuca alternifolia oil test groups showed a 72% improvement. A higher concentration of the oil is thus required for treating this type of infection.

In spite of the dermatophytes showing susceptibility to essential oils, there are few studies dedicated to these pathogens. One would expect more essential oil treatments considering the difficulty in treating these infections which require expensive prolonged treatment. An essential oil with superior activity certainly warrants further investigation, particularly as essential oils work well on skin surfaces and are shown to display good penetration capabilities [283, 284]. Madurella mycetomatis and Malassezia furfur are sorely neglected pathogens in research. Possibly their fastidious nature acts as a barrier for further research. As far as clinical studies are concerned, essential oils against fungal pathogens have also been neglected. Only M. alternifolia oil has been clinically studied extensively with investigations incorporating onychomycosis, tinea pedis, and dandruff [275, 279, 281, 282, 285]. It would be interesting to observe the antidermatophytic property of essential oils that have shown to be noteworthy in vitro antifungal activity such as for Apium nodiflorum (celery), Cedrus atlantica (cedar wood), C. citratus, Juniperus oxycedrus ssp. oxycedrus (cade), Pelargonium graveolens (geranium), S. aromaticum, and Thymus spp.

5. Essential Oil Combinations

Other than the use of oils within carrier oils, most essential oils are used in blends or combinations of two or more oils [32]. These blends are considered to be an art where the oils are carefully selected and combined with the intention of holistically healing the “whole” individual according to his/her symptoms. The goal of blending is to create a synergistic therapeutic effect where the combination of essential oils is greater than the sum of the individual oil [37, 40, 286]. The beneficial value of synergy has been notorious and used since antiquity [74]. Synergy can be achieved if the compounds in the oil are able to affect different target sites, or they may interact with one another to increase solubility thereby enhancing bioavailability [287289]. Mechanisms that can lead to pharmacological synergy are (1) multitarget effect where multiple target sites of the bacterial cell are affected; (2) solubility and bioavailability enhancement; (3) the mechanism where the essential oil may inhibit the mutation mechanism of bacteria to the antimicrobial; or (4) the mechanism where the essential oil may inhibit the efflux pump of bacteria, thus allowing for the antimicrobial to accumulate inside the bacteria [11, 288, 290]. The goal is for a multitargeted treatment to decrease pathogen mutation and thus retard the development of resistance. The combined formulation also has the potential to decrease toxicity and adverse side effects by lowering the required dose [290292]. This is not an infallible method, however, as even the combined penicillin with clavulanic acid has become prone to resistance [293, 294].

When blends are created, the intention is to create therapeutic synergy [2, 26, 32]. The reasoning for the combinations is to produce a forceful blend that has more than one mode of action. For example, in the treatment of abscesses, C. bergamia and L. angustifolia may be used in combination. C. bergamia is used for its antiseptic properties and L. angustifolia for antiseptic and anti-inflammatory effects. Anthemis nobilis is also often used for anti-inflammatory effects [2, 26, 32, 37]. The theory is sound and not too far off considering that numerous essential oils have been proven to possess additional pharmacological properties. For example, P. graveolens is known for antiseptic and anti-inflammatory properties. It is often used for the ability to balance sebum secretions and clear oily and sluggish skin [295]. Eucalyptus globulus (eucalyptus) may be used for its proven antimicrobial and anti-inflammatory activity [296, 297]. Often used on acne prone skin because of its antiseptic properties is L. angustifolia [298, 299]. Anthemis nobilis is believed to ease inflammation and L. angustifolia assists with healing and regeneration [25]. Citrus aurantium (neroli) flower oil has displayed antioxidant activity [120], and the main component of M. alternifolia (terpinen-4-ol) has the ability to hinder tumour necrosis factor (TNF), interleukin-1, interleukin-8, and interleukin-10, and prostaglandin [300]. The anti-inflammatory activity of C. bergamia has been proven by several studies in vitro or on animal models [301, 302]. This supports the theory behind therapeutic synergy; however, the mistaken belief that any essential oil blend will result in synergy is not fully accurate [33]. It is a complex area, because although a certain combination may have a synergistic therapeutic effect, it does not necessarily translate into antimicrobial synergy and this needs further investigation.

By reviewing the aromatherapeutic literature [1, 2, 26, 32, 3643], at least 1500 possible combinations (made up of two oils) could be identified for dermatology alone. This brings forth the question as to the antimicrobial effect of the overall combination. After all, if essential oils are to be investigated as options to curb antimicrobial resistance, the aim of combination therapy should be to broaden the spectrum of the antimicrobial activity and prevent development of additional resistance occurring [96]. The risk of resistance emerging against essential oils should not be disregarded because suboptimal doses of essential oils may impact these phenomena [303]. Sublethal concentration exposure to M. alternifolia has been proven to result in slightly lowered bacterial susceptibility to M. alternifolia and a larger decrease in susceptibility to conventional antimicrobials. The study concluded that essential oil products containing sublethal concentrations may result in stress-hardened (mutated) S. aureus isolates and possible treatment failure [146]. This highlights that although therapeutic synergy is strived for, these must still be verified in a controlled environment [288].

Studies have proven that essential oils, whether in combination with other essential oils [99] or in combination with conventional antimicrobials [304], can initiate a synergistic antimicrobial effect. This effect, however, is limited to the studied pathogen [290]. de Rapper et al. [99] demonstrated that even when essential oils displayed synergistic blends against one pathogen, the same could not be said against other pathogens. This highlights how the assumption should not be made that all synergistic blends are the same against all pathogens.

The fractional inhibitory concentration index ( or FICI) is the commonly accepted mathematical method employed to interpret interactions in 1 : 1 combinations [74]. is determined from the sum of all individual FICs of each of the test agents within the combination [305]. This then allows for the determination of their individual interactions in the combination [306]. The results are interpreted as synergistic ( ≤ 0.5), additive ( > 0.5–1.0), indifferent (>1.0 ≤ 4.0), or antagonistic ( > 4.0) [74]. Although using calculations is an easy method, it is not without its limitation. When examining 1 : 1 ratios between two essential oils, it is assumed that half the concentration will only offer half the effect. This is not necessarily the case between agents, as two agents may not have the same dose response at the same concentrations [307]. An interactive assessment of the different ratio combinations is mostly carried out using the isobole method [308, 309]. This method allows for more accurate valuation of the combination contribution made by each agent on a mathematical level line where all points are collected on a surface that lies at a specific value [288, 305, 310]. There are, however, other complex methods that can also be used [311, 312].

5.1. Essential Oils in Combination with Other Essential Oils

Although combinations are frequently mentioned in aromatherapy to treat skin ailments, only a handful of studies documenting essential oil combinations were found against skin pathogens (Table 9). The combination studies are predominantly limited to S. aureus, P. aeruginosa, C. albicans, and, to a lesser extent, E. coli. Even fewer studies were found against the dermatophytes and acne pathogens. This is rather abysmal considering the amount of combinations and the regularity of their use. An interesting observation was made even in an early study [316], where it was shown that synergy found in the 1 : 1 combinations was apparent irrespective of the poor efficacy displayed by the individual oils. This indicates that essential oils do not necessarily have to be combined based purely on independent noteworthy antimicrobial activity.

Table 9: Essential oil with essential oil combinations against skin pathogens.

One of the largest studies on combinations was done by de Rapper et al. [99], where 45 essential oils were combined with L. angustifolia, which is one of the most popular essential oils used in combination. What could be observed was that there was no predictive pattern as to what the combined FIC index would be. There were a few synergistic interactions, most of which against C. albicans and some antagonism; however, the majority of the combinations resulted in an indifferent or additive interaction. A study investigated the antimicrobial activity of the popular commercial product containing essential oils (Olbas). The individual essential oils were tested separately and then in the combined product [128]. The combination of the four oils showed no further enhancement in the antimicrobial. The combination of Syzygium aromaticum (clove) and Rosmarinus officinalis (rosemary) has also displayed synergy against C. albicans, at ratios of 1 : 5, 1 : 7, and 1 : 9 [169]. Synergy was observed with a combination of commercially popular L. angustifolia and M. alternifolia essential oils against dermatophytes T. rubrum and T. mentagrophytes var. interdigitale in various combinations [303]. Unfortunately, only a few essential oil combinations have been investigated in clinical settings.

Essential oil combinations have proven efficacy in clinical settings. L. angustifolia and Matricaria recutita (German chamomile) were investigated in a small trial involving eight patients with chronic leg ulcers. Five received a 6% mixture of the two essential oils mixed in Vitis vinifera (grape seed) carrier oil, and three received conventional wound care. It was noted that four of the five patients in the control group had complete healing of the wounds with the fifth patient making progress towards a recovery [317]. Another successful essential oil combination included L. angustifolia, Artemisia vulgaris (mugwort), and Salvia officinalis (sage) in treating chronic wounds such as venous ulcers, pressure sores, skin tears, and abrasions. It was speculated that the essential oils had increased circulation and vascular permeability resulting in accelerated angiogenesis [318]. An in vivo study by Mugnaini et al. [266] made use of a mixture composed of 5% O. vulgare, 5% R. officinalis, and 2% Thymus serpyllum (Breckland thyme), diluted in Prunus dulcis (sweet almond), and this was topically administered on M. canis lesions. A 71% success rate in treatment was observed.

5.2. Essential Oils in Combination with Conventional Antimicrobials

In an effort to prevent resistance and increase antimicrobial efficacy against multidrug-resistant bacteria, the combination of essential oils with antibiotics has been investigated [182, 319321]. Certain studies are based on the assumption that the antimicrobial and essential oils attack at different sites of the pathogen [304], while others believe this is due to the increase in chemical complexity, together with the added advantage of enhanced skin penetration by the essential oil components [322], or the hope that the essential oils will improve antibiotic diffusion across the bactericidal cell membranes and/or inhibit the Gram-negative efflux pump [323]. Conventional medication in combination with essential oils (bought over the counter or shelves) is also common among patients [183]; therefore, unknowingly, they may be causing enhancement or failure.

Table 10 displays the studies validating the improvement of antimicrobial activity from the combined use of antimicrobials with essential oils. The majority of the studies have shown essential oils to enhance antimicrobial activity of antibiotics and antifungals [81, 346, 347]. Origanum vulgare oil displayed synergy (FICs 0.4–0.5) when combined with doxycycline, florfenicol, or sarafloxacin against an ESBL producing E. coli [324]. This presents a possible solution for β-lactamase antibiotic-resistant bacteria. Origanum vulgare essential oils were investigated and shown to improve the activity of β-lactam antibiotics against both Gram-positive and Gram-negative β-lactamase-producing bacteria [77, 324]. Helichrysum italicum (everlasting) (2.5%) reduced the multidrug resistance of Gram-negative bacteria, E. coli and P. aeruginosa, to chloramphenicol [320].

Table 10: Essential oil studies demonstrating synergistic interactions in combination with conventional antimicrobials.

Four community-associated methicillin-resistant S. aureus (CA-MRSA) isolates were used to compare benzethonium chloride 0.2% with M. alternifolia and T. vulgaris combination with conventional antimicrobials (neomycin with polymyxin B sulphate and polymyxin B sulphate with gramicidin). The essential oil-antibiotic combination was found to be more effective than conventional medicines on their own [348]. In another study, however, where M. piperita, M. alternifolia, T. vulgaris, and R. officinalis were each individually combined with amphotericin B against C. albicans, antagonism was observed [304], indicating that there may still be risks present when combining essential oils with antimicrobials. Cinnamomum cassia showed potentiation of amphotericin B activity against C. albicans. The increased activity was attributed to the essential oil because synergy increased with an increase in essential oil concentration; however, antagonism was observed for combinations with a lower concentration of essential oil [238].

Although there have been some studies in vitro on essential oil combinations with antibiotics and antifungals, little attention has been paid to in vivo studies or clinical trials. Syed et al. [285] tested a 2% butenafine hydrochloride combination with a 5% M. alternifolia oil cream in a clinical trial, consisting of 60 patients, treating toenail onychomycosis. The control group showed an 80% cure rate compared to 0% by the placebo group containing M. alternifolia alone, allowing the study to conclude clinical effectiveness of butenafine hydrochloride and M. alternifolia in combination. However, in order to determine whether the same could be said for butenafine, a control group should have also been allowed for this product to allow for comparison.

6. Antiviral Studies

Viral infections are a worldwide threat, firstly due to the lack of effective treatments available and secondly due to resistance [333]. Essential oils are a potential source for novel medicines in this regard [30]. Certain essential oils have previously displayed antiviral activity [30, 334], with the best viral inhibitors specifically acting on the steps involved in viral biosynthesis. These work by inhibiting viral replication, thereby limiting viral progeny production [30]. It is advantageous that the viral replication cycle consists of a complex sequence of different steps because it increases the chance of interference from antiviral agents [30].

Less than half of the essential oils recommended for skin infections have been studied for antiviral activity. Table 11 records the readily available studies. The most studied virus is the herpes simplex virus (HSV) and the most studied essential oil is M. alternifolia.

Table 11: Essential oil studies showing efficacy against viral pathogens associated with skin infections.

Antiviral studies encompass an extensive process where the cytotoxicity and antiviral activity need to be determined. Antiviral activity is usually tested via the plaque reduction assay on Vero (African green monkey kidney cells) cells infected with the virus. This assay determines the effective concentration inhibiting 50% of virus growth (IC50). The selective indicator or selectivity index is calculated with the equation of CC50/IC50. An essential oil with a SI value greater than four is considered suitable as an antiviral agent [332, 333]. Besides the criteria being made for the SI, no criteria for the IC50 have been made. According to the results reviewed, an IC50 value of less than 0.0010% or 1.00 μg/mL should be considered as noteworthy.

Essential oils recommended in the aromatherapeutic literature, with supporting in vitro evidence, include Citrus limon (lemon), Lavandula latifolia (lavender), M. piperita, Santolina insularis (santolina), M. alternifolia, E. globulus, and S. officinalis. Of these oils, the latter three are not ideally suited for antiviral use against HSV-1, due firstly to the IC50 values being weaker than what is recommended (less than 0.0010% or 1.00 μg/mL) and due to their low selectivity index (below 4) [331, 332, 334, 340, 341]. Essential oils still to be studied according to the literature include C. zeylanicum, C. bergamia, Pelargonium odoratissimum (geranium), and Tagetes minuta (Mexican marigold).

In a small pilot study, consisting of 18 patients undergoing treatment of recurrent herpes labialis, a 6% M. alternifolia oil gel applied five times daily was compared to a placebo gel [349]. Reepithelialisation occurred after nine days for the test group compared to the placebo group where reepithelialisation occurred only after 12.5 days. Millar and Moore [350], undertook a case study of a patient with six reoccurring warts (human papillomavirus) after countless treatments with 12% w/w salicylic acid and lactic acid (4% w/w) for several weeks. Alternative treatment consisted of 100% topical M. alternifolia oil applied each evening straight after bathing and prior to bedtime. After five days, a significant reduction in wart size was observed, and, after an additional seven days, all warts were cleared, with complete reepithelialisation of the infected areas and no recurrence. The main shortfall of the two studies is the small sample size. It should also be recommended that any trial involving viral pathogens include a one-, two-, and six-month follow-up after the discontinuation of treatment, the reason being due to the tendency of viral pathogens remaining dormant for an extended period. It can then be observed how effective the essential oil is for long-term effects.

The nonenveloped (such as HPV) viruses have thus far been shown to be more resilient to essential oils [30] compared to the enveloped viruses (HSV) which are more susceptible to essential oils that could dissolve the lipid membrane [5]. Essential oil studies against viruses are clearly lacking. The most studied virus is HSV, which is one of the most prevalent viruses [351], and the most studied essential oil is M. alternifolia. Although numerous studies have proven efficacy of tea tree oil, the problem with a few of the studies is that these were compared to a placebo, which is expected to display poor activity.

Although these studies demonstrate some antiviral activity, other viral pathogens (e.g., varicella zoster, herpes zoster, human papillomavirus, and Molluscum contagiosum) associated with skin infections have clearly been neglected and warrant further study.

7. Essential Oil Toxicity

Plants used for therapeutic purposes are normally assumed to be safe and free of toxicity. This misconception is mainly due to the long-term usage of medicinal plants for the treatment of diseases based on basic knowledge accumulated and shared from generation to generation over many centuries. However, scientific studies and reports have highlighted the toxic effects of essential oils used to treat skin ailments, which are known to produce adverse effects such as allergic contact dermatitis, skin irritation, or photosensitization [300]. Phenols and aldehyde containing oils may often cause irritation [352]. Furanocoumarin containing essential oils (such as C. bergamia) have been proven to induce phototoxicity [353355]. The evidence based review on botanicals in dermatology by Reuter et al. [18] identifies certain medicinal plants which have been used for dermatological purposes, which have also reported toxic effects. These include C. bergamia and M. recutita. Mentha piperita oil has been reported to cause dermal irritation [356]. Prashar et al. [357] have shown in an in vitro study that L. angustifolia oil and linalool (one of the main compounds) are cytotoxic to human fibroblast and endothelial cells [357]. There have also been a few case reports on L. angustifolia use resulting in contact dermatitis [358360].

Stonehouse and Studdiford [361] determined that nearly 5% of patients that use M. alternifolia oil will experience allergic contact dermatitis. Centred on a patch test study of 311 volunteers, it was determined that neat 5% tea tree oil can cause irritancy (mean irritancy score of 0.25) [362]. In contrast, however, the study of 217 patients from a dermatology clinic, subjected to a patch test with 10% M. alternifolia oil, showed no irritation [363]. Two additional studies tested the M. alternifolia in patch tests at concentrations of 5% and 10%; 0.15–1.8% of patients experienced allergic contact dermatitis [364, 365]. However, considering that patch tests exaggerate real-world product use [366, 367], they do not necessarily give a good indication of products containing the essential oils. This is evident in the discussed clinical trials using M. alternifolia oil where only mild reactions were observed [189, 200, 219, 281, 282, 285]. Increasing the oil concentration to 25–100%, however, resulted in an increased risk of contact dermatitis in 2–8% of patients [275, 279]. Several additional reports exist reporting contact dermatitis and one systemic hypersensitivity reaction, from the use of M. alternifolia [368371].

As the prospective use of these essential oils may be for topical application, it is necessary to test toxicity against skin fibroblasts and human skin cell lines F1-73 [115]. Backhousia citriodora oil at a concentration of 1.00% showed low toxicity to human skin cells and skin fibroblasts [115], whereas neat B. citriodora oil and citral were shown to be toxic to human skin cells (F1-73) and skin fibroblasts [115]. Thymus quinquecostatus, when tested against fibroblast cells for cytotoxicity, showed low cytotoxicity at concentrations below 12.5 μg/mL in fibroblast cells and thus may be suitable for topical treatment [207]. Mentha piperita is one of the most popularly used essential oils [372]; however, there have been reports that M. piperita oil can cause both dermal irritations [356]. A review by Reichling et al., containing more information regarding essential oil toxicity, is available [30].

8. Conclusion

Of all the skin pathogens studied, dermatophytes were found to be the most sensitive to essential oil inhibition, followed by the yeast C. albicans and then Gram-positive bacteria (anaerobes more than aerobes), with Gram-negative bacteria being the most resistant, especially P. aeruginosa [168, 181]. The most frequently studied organisms are E. coli, P. aeruginosa, C. albicans, and S. aureus. However, less attention has been paid to pathogens such as S. epidermidis, H. influenzae, S. pyogenes, P. acnes, Clostridium spp., Brevibacterium spp., and the dermatophytes. The reason for this may be due to the difficulty in performing such studies on fastidious pathogens and the lack of a perceived threat. Furthermore, many of these pathogens are slow growing and, combined with the volatile nature of oils, may prove difficult in retaining the oil with the pathogen during the incubation period. Where possible, resistant strains should be included in essential oil studies, along with the reference strain [56, 147]. Antiviral studies should extend to the neglected viruses. These should also report on which part of the cycle the inhibition occurred. The focus should be directed towards the aromatherapeutic recommendation of the essential oil and the responsible pathogens connected to the type of infection, together with the inclusion of the microorganism strain number, the solvent, essential oil composition, and the reason for testing. This is especially relevant for combination studies where it is ill advised to just randomly test different combinations.

Regardless of the frequency of the therapeutic claims made for essential oils and the proven in vitro activity, most evidence of the therapeutic efficacy of aromatherapy has been published in books about aromatherapy and not in peer-reviewed journals. A few clinical trials have emerged, but their results are rarely confirmed completely to substantiate essential oil effectiveness. More rigorous clinical trials would establish confidence from the medical professionals [352].

Besides the antimicrobial activities, toxicity studies are also recommended using skin fibroblasts for sensitivity, as the use is topical. The toxicological effects of essential oils are important facets that need to be addressed. Discernment also needs to be applied as certain sensitivity studies may have been done on rabbit skin; however, human skin has been found to be more sensitive to irritants [115].

Further essential oil combinations need to be studied, along with the reason for the combination selection. Whether the interaction is synergistic, additive, indifferent, or antagonistic, each interaction is a valuable result. If antagonism is not reported, it will not be known to avoid those combinations, which in turn will result in their continuous use, which may eventually lead to resistance to the essential oils themselves. Including synergistic results will allow for these essential oil combinations to be used more frequently in practice. The inclusion of additive and indifferent interactions is also vital in order to report essential oil combinations already studied. This will prevent unnecessary duplication of combination research and confirm essential oil combinations that have useful antimicrobial activity. This research will provide an insight into the understanding of these combinations which could allow for newer directives for integrating essential oils into mainstream medicine. Although essential oil combinations with other essential oils and with antimicrobials have started gaining some attention, there is still a gap in the research with regard to carrier oils. Essential oils are seldom used directly on the skin because direct use onto the skin can cause irritation [26, 38]. Therefore, essential oils are blended with carrier oils before they are applied to the skin. This raises the question as to whether or not the carrier oils influence the overall antimicrobial activity of the essential oils. Gemeda et al. [373] tested the antimicrobial activity of essential oils mixed in different hydrophilic and lipophilic bases. They found better effects in hydrophilic bases than in lipophilic bases. This study confirmed that the base may have an influence on the antimicrobial activity; however, carrier oils in combination have to the best of our knowledge not been studied further.

Essential oils, such as M. alternifolia, are often used in subinhibitory concentrations in commercial products such as shampoos, shower gels, and creams to enhance commercial selling point of a greener product or improve fragrance or desire for the product [202]. This in itself can cause resistance. Therefore, although essential oils are showing promise, the use of essential oils in subinhibitory concentrations in cosmetics and other dermatological formulations may weaken the efficacies of the essential oils as antiseptics, as was shown by Nelson [136]. This highlights the need to insure that there is sufficient evidence supporting aromatherapeutic combinations not only for therapeutics, but also in commercial products.

Resistant strains such as P. aeruginosa, MRSA, and methicillin-resistant S. epidermidis (MRSE) have become extensively problematic microorganisms in the recent years due to their antimicrobial resistance [158], and, as such, including these organisms in screening studies is becoming more and more important.

For viral studies, one needs to consider that genuine antiviral potential is seen for those essential oils that display activity after absorption into the host cell’s nucleus because this is where viral DNA replicates by using viral DNA polymerase [30].

Clinical trial and ex vivo studies should consider regular essential oil dosing, instead of once daily, or every several days, application. According to the aromatherapeutic literature, essential oils are generally applied two to three times a day. The reason may be due to the volatile nature resulting in essential oil evaporation. Thus, in order to give credit to essential oil use, application studies should consider timed dosages.

Finally, M. alternifolia is the most studied of all commercial essential oils. However, many other oils have shown better antimicrobial activity. It is time essential oil researchers give just as much attention to oils such as C. zeylanicum, L. scoparium, O. vulgare, S. album, and S. aromaticum in the hope of increasing the global knowledge of essential oils used on the skin.

Competing Interests

The authors declare no competing interests regarding the publication of this paper.

Acknowledgments

The authors are thankful to the bursary funding from NRF.

References

  1. S. Clarke, Essential Chemistry for Aromatherapy, Churchill Livingstone, London, UK, 2008.
  2. G. Farrer-Halls, The Aromatherapy Bible: The Definitive Guide to Using Essential Oils, Bounty Books, London, UK, 2011.
  3. B. Dixon, “Cheese, toes, and mosquitoes,” British Medical Journal, vol. 312, no. 7038, p. 1105, 1996. View at Publisher · View at Google Scholar
  4. C. A. Mims, J. Playfair, I. Roitt, D. Wakelin, and R. Williams, Medical Microbiology, Mosby, Detroit, Mich, USA, 1998.
  5. B. A. Bannister, N. T. Begg, and S. H. Gillepsie, Infectious Disease, Blackwell Science, New York, NY, USA, 2000.
  6. M. Wilson, Microbial Inhabitants of Humans, their Ecology and Role in Health and Disease, Cambridge University Press, Cambridge, UK, 2005.
  7. N. C. Cevasco and K. J. Tomecki, Common skin infections. Disease Management Project 2012, 2013, http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/dermatology/common-skin-infections.
  8. M. S. Dryden, “Complicated skin and soft tissue infection,” Journal of Antimicrobial Chemotherapy, vol. 65, supplement 3, pp. iii35–iii44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. P. Davis, “Normal flora,” in Medical Microbiology, S. Baron, Ed., chapter 6, University of Texas Medical Branch at Galveston, Galveston, Tex, USA, 1996. View at Google Scholar
  10. D. L. Stulberg, M. A. Penrod, and R. A. Blatny, “Common bacterial skin infections,” American Family Physician, vol. 66, no. 1, pp. 119–124, 2002. View at Google Scholar · View at Scopus
  11. S. Hemaiswarya, A. K. Kruthiventi, and M. Doble, “Synergism between natural products and antibiotics against infectious diseases,” Phytomedicine, vol. 15, no. 8, pp. 639–652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Greenwood, R. Slack, J. Peutherer, and M. Barer, Medical Microbiology, A Guide to Microbial Infections: Pathogenesis, Immunity, Laboratory Diagnosis and Control, Churchill Livingstone, Philadelphia, Pa, USA, 2007.
  13. L. E. Millikan, “Complementary medicine in dermatology,” Clinics in Dermatology, vol. 20, no. 5, pp. 602–605, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Ranzato, S. Martinotti, and B. Burlando, “Wound healing properties of jojoba liquid wax: an in vitro study,” Journal of Ethnopharmacology, vol. 134, no. 2, pp. 443–449, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Iossifova, A. Kujumgiev, A. Ignatova, E. Vassileva, and I. Kostova, “Antimicrobial effects of some hydroxycoumarins and secoiridoids from Fraxinus ornus bark,” Pharmazie, vol. 49, no. 4, pp. 298–299, 1994. View at Google Scholar · View at Scopus
  16. L. Halcón and K. Milkus, “Staphylococcus aureus and wounds: a review of tea tree oil as a promising antimicrobial,” American Journal of Infection Control, vol. 32, no. 7, pp. 402–408, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. N. B. Menke, K. R. Ward, T. M. Witten, D. G. Bonchev, and R. F. Diegelmann, “Impaired wound healing,” Clinics in Dermatology, vol. 25, no. 1, pp. 19–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Reuter, I. Merfort, and C. M. Schempp, “Botanicals in dermatology: an evidence-based review,” American Journal of Clinical Dermatology, vol. 11, no. 4, pp. 247–267, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Walsh, Golden Age' of Antibiotics ‘Set to End’, BBC News Website, 2014.
  20. Z. F. Udwadia, R. A. Amale, K. K. Ajbani, and C. Rodrigues, “Totally drug-resistant tuberculosis in India,” Clinical Infectious Diseases, vol. 54, no. 4, pp. 579–581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. S. Dryden, A. T. Andrasevic, M. Bassetti et al., “A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice,” Clinical Microbiology and Infection, vol. 16, no. 1, pp. 3–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Gallagher, Analysis: Antibiotic Apocalypse, BBC News, 2013.
  23. G. C. Bodeker, T. J. Ryan, and C.-K. Ong, “Traditional approaches to wound healing,” Clinics in Dermatology, vol. 17, no. 1, pp. 93–98, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Nakatsu, A. T. Lupo Jr., J. W. Chinn Jr., and R. K. L. Kang, “Biological activity of essential oils and their constituents,” Studies in Natural Products Chemistry, vol. 21, pp. 571–631, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Buckle, Clinical Aromatherapy: Essential Oils in Practice, Churchill Livingston, New York, NY, USA, 2003.
  26. M. Evans, Natural Healing: Remedies & Therapies, Hermes House, London, UK, 2010.
  27. M. S. Lee, J. Choi, P. Posadzki, and E. Ernst, “Aromatherapy for health care: an overview of systematic reviews,” Maturitas, vol. 71, no. 3, pp. 257–260, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. H. D. Neuwinger, African Traditional Medicine—A Dictionary of Plant Use and Applications, Medpharm, Stuttgart, Germany, 2000.
  29. V. K. Bajpai, J. I. Yoon, and S. C. Kang, “Antifungal potential of essential oil and various organic extracts of Nandina domestica Thunb. against skin infectious fungal pathogens,” Applied Microbiology and Biotechnology, vol. 83, no. 6, pp. 1127–1133, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Reichling, P. Schnitzler, U. Suschke, and R. Saller, “Essential oils of aromatic plants with antibacterial, antifungal, antiviral, and cytotoxic properties-an overview,” Research in Complementary Medicine, vol. 16, no. 2, pp. 79–90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. “More evidence is needed to confirm the benefits and risks of many botanicals in dermatology,” Drugs & Therapy Perspectives, vol. 27, no. 7, pp. 24–26, 2011. View at Publisher · View at Google Scholar
  32. J. Lawless, The Illustrated Encyclopedia of Essential Oils: The Complete Guide to the Use of Oils in Aromatherapy and Herbalism, Element Books, Rockport, Mass, USA, 1995.
  33. M. Lis-Balchin, “Essential oils and ‘aromatherapy’: their modern role in healing,” The Journal of the Royal Society for the Promotion of Health, vol. 117, no. 5, pp. 324–329, 1997. View at Google Scholar
  34. C. J. Stevensen, “Aromatherapy in dermatology,” Clinics in Dermatology, vol. 16, no. 6, pp. 689–694, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Maddocks-Jennings and J. M. Wilkinson, “Aromatherapy practice in nursing: literature review,” Journal of Advanced Nursing, vol. 48, no. 1, pp. 93–103, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Sellar, The Directory of Essential Oils, C. W. Daniel Company, London, UK, 1992.
  37. S. Curtis, Essential Oils, Aurum Press, London, UK, 1996.
  38. J. Harding, A Guide to Essential Oils, Parragon, Bath, UK, 2002.
  39. Ark Creative, Just Aromatherapy, Top That! Publishing, Valencia, Calif, USA, 2005.
  40. J. Harding, The Essential Oils Handbook, Duncan Baird, London, UK, 2008.
  41. M. Kovac, A Quick Guide to Essential Oils, Aromadelavnice s.p., Ljubljana, Slovenia, 2011.
  42. Meadowbank, Ailments leaflet-find an essential oil for your ailment, 2012.
  43. Burgess and Finch, Burgess and Finch Aromatherapy: Patient Leaflet, 2013.
  44. J. Viyoch, N. Pisutthanan, A. Faikreua, K. Nupangta, K. Wangtorpol, and J. Ngokkuen, “Evaluation of in vitro antimicrobial activity of Thai basil oils and their micro-emulsion formulas against Propionibacterium acnes,” International Journal of Cosmetic Science, vol. 28, no. 2, pp. 125–133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. M. J. Gonçalves, A. M. Vicente, C. Cavaleiro, and L. Salgueiro, “Composition and antifungal acticvity of the essential oil of Mentha cervia from Portugal,” Natural Product Research, vol. 21, no. 10, pp. 867–871, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Deriu, S. Zanetti, L. A. Sechi et al., “Antimicrobial activity of Inula helenium L. essential oil against Gram-positive and Gram-negative bacteria and Candida spp.,” International Journal of Antimicrobial Agents, vol. 31, no. 6, pp. 588–590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Kirmizibekmez, B. Demirci, E. Yeşilada, K. H. C. Başer, and F. Demirci, “Chemical composition and antimicrobial activity of the essential oils of Lavandula stoechas L. ssp. stoechas growing wild in Turkey,” Natural Product Communications, vol. 4, no. 7, pp. 1001–1006, 2009. View at Google Scholar · View at Scopus
  48. H. Nguyen, E. M. Campi, W. R. Jackson, and A. F. Patti, “Effect of oxidative deterioration on flavour and aroma components of lemon oil,” Food Chemistry, vol. 112, no. 2, pp. 388–393, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Turek and F. C. Stintzing, “Impact of different storage conditions on the quality of selected essential oils,” Food Research International, vol. 46, no. 1, pp. 341–353, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. L. Riahi, M. Elferchichi, H. Ghazghazi et al., “Phytochemistry, antioxidant and antimicrobial activities of the essential oils of Mentha rotundifolia L. in Tunisia,” Industrial Crops and Products, vol. 49, pp. 883–889, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. J. R. Calo, P. G. Crandall, C. A. O'Bryan, and S. C. Ricke, “Essential oils as antimicrobials in food systems—a review,” Food Control, vol. 54, pp. 111–119, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. G. B. Lockwood, “Techniques for gas chromatography of volatile terpenoids from a range of matrices,” Journal of Chromatography A, vol. 936, no. 1-2, pp. 23–31, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Lahlou, “Methods to study the phytochemistry and bioactivity of essential oils,” Phytotherapy Research, vol. 18, no. 6, pp. 435–448, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. S. F. van Vuuren, The antimicrobial activity and essential oil composition of medicinal aromatic plants used in African traditional healing [Ph.D. thesis], University of Witwatersrand, Johannesburg, South Africa, 2007.
  55. A. Elaissi, Z. Rouis, S. Mabrouk et al., “Correlation between chemical composition and antibacterial activity of essential oils from fifteen Eucalyptus species growing in the Korbous and Jbel Abderrahman arboreta (North East Tunisia),” Molecules, vol. 17, no. 3, pp. 3044–3057, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. S. F. van Vuuren, “Antimicrobial activity of South African medicinal plants,” Journal of Ethnopharmacology, vol. 119, no. 3, pp. 462–472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. A. M. Janssen, J. J. C. Scheffer, and A. B. Svendsen, “Antimicrobial activity of essential oils: a 1976–1986 literature review. Aspects of the test methods,” Planta Medica, vol. 53, no. 5, pp. 395–398, 1987. View at Publisher · View at Google Scholar · View at Scopus
  58. J. L. Rios, M. C. Recio, and A. Villar, “Screening methods for natural products with antimicrobial activity: a review of the literature,” Journal of Ethnopharmacology, vol. 23, no. 2-3, pp. 127–149, 1988. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Pauli and H. Schilcher, “In Vitro antimicrobial activities of essential oils monographed in the European Pharmacopoeia,” in Handbook of Essential Oils: Science, Technology, and Applications, K. H. C. Baser and G. Buchbauer, Eds., pp. 353–547, CRC Press, Taylor & Francis Group, Boca Raton, Fla, USA, 2010. View at Google Scholar
  60. Z. Xiangwei, W. Xiaodong, N. Peng, Z. Yang, and C. Jiakuan, “Chemical composition and antimicrobial activity of the essential oil of Sagittaria trifolia,” Chemistry of Natural Compounds, vol. 42, no. 5, pp. 520–522, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. M. C. Rota, A. Herrera, R. M. Martínez, J. A. Sotomayor, and M. J. Jordán, “Antimicrobial activity and chemical composition of Thymus vulgaris, Thymus zygis and Thymus hyemalis essential oils,” Food Control, vol. 19, no. 7, pp. 681–687, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. F. Lv, H. Liang, Q. Yuan, and C. Li, “In vitro antimicrobial effects and mechanism of action of selected plant essential oil combinations against four food-related microorganisms,” Food Research International, vol. 44, no. 9, pp. 3057–3064, 2011. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Saïdana, M. A. Mahjoub, O. Boussaada et al., “Chemical composition and antimicrobial activity of volatile compounds of Tamarix boveana (Tamaricaceae),” Microbiological Research, vol. 163, no. 4, pp. 445–455, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Pauli and K. H. Kubeczka, “Evaluation of inhibitory data of essential oil constituents obtained with different microbiological testing methods,” in Essential Oils: Basic and Applied Research, C. H. Franz, A. Mathe, and G. Buchbauer, Eds., pp. 33–36, Allured Publishing Corporation, Carol Stream, Ill, USA, 1997. View at Google Scholar
  65. D. Kalemba and A. Kunicka, “Antibacterial and antifungal properties of essential oils,” Current Medicinal Chemistry, vol. 10, no. 10, pp. 813–829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. J. L. Ríos and M. C. Recio, “Medicinal plants and antimicrobial activity,” Journal of Ethnopharmacology, vol. 100, no. 1-2, pp. 80–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. P. Cos, A. J. Vlietinck, D. V. Berghe, and L. Maes, “Anti-infective potential of natural products: how to develop a stronger in vitro ‘proof-of-concept’,” Journal of Ethnopharmacology, vol. 106, no. 3, pp. 290–302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. G. Lang and G. Buchbauer, “A review on recent research results (2008–2010) on essential oils as antimicrobials and antifungals. A review,” Flavour and Fragrance Journal, vol. 27, no. 1, pp. 13–39, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. R. J. W. Lambert and J. Pearson, “Susceptibility testing: accurate and reproducible minimum inhibitory concentration (MIC) and non-inhibitory concentration (NIC) values,” Journal of Applied Microbiology, vol. 88, no. 5, pp. 784–790, 2000. View at Publisher · View at Google Scholar · View at Scopus
  70. Y. X. Seow, C. R. Yeo, H. L. Chung, and H.-G. Yuk, “Plant essential oils as active antimicrobial agents,” Critical Reviews in Food Science and Nutrition, vol. 54, no. 5, pp. 625–644, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. N. P. Varela, R. Friendship, C. Dewey, and A. Valdivieso, “Comparison of Agar Dilution and E-test for antimicrobial susceptibility testing of Campylobacter coli isolates recovered from 80 Ontario swine farms,” The Canadian Journal of Veterinary Research, vol. 72, no. 2, pp. 168–174, 2008. View at Google Scholar · View at Scopus
  72. A. S. Beale and R. Sutherland, Measurement of Combined Antibiotic Action in Antibiotics: Assessment of Antimicrobial Activity and Resistance, Academic Press, London, UK, 1983.
  73. M. Dufour, R. S. Simmonds, and P. J. Bremer, “Development of a method to quantify in vitro the synergistic activity of ‘natural’ antimicrobials,” International Journal of Food Microbiology, vol. 85, no. 3, pp. 249–258, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. S. F. van Vuuren and A. M. Viljoen, “Plant-based antimicrobial studies—methods and approaches to study the interaction between natural products,” Planta Medica, vol. 77, no. 11, pp. 1168–1182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. V. Agarwal, P. Lal, and V. Pruthi, “Effect of plant oils on Candida albicans,” Journal of Microbiology, Immunology and Infection, vol. 43, no. 5, pp. 447–451, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Hadad, J. A. Zygadlo, B. Lima et al., “Chemical composition and antimicrobial activity of essential oil from Baccharis grisebachii hieron (asteraceae,” Journal of the Chilean Chemical Society, vol. 52, no. 2, pp. 1186–1189, 2007. View at Google Scholar
  77. A. M. A. Nascimento, M. G. L. Brandão, G. B. Oliveira, I. C. P. Fortes, and E. Chartone-Souza, “Synergistic bactericidal activity of Eremanthus erythropappus oil or β-bisabolene with ampicillin against Staphylococcus aureus,” Antonie van Leeuwenhoek, vol. 92, no. 1, pp. 95–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. G. N. Teke, K. N. Elisée, and K. J. Roger, “Chemical composition, antimicrobial properties and toxicity evaluation of the essential oil of Cupressus lusitanica Mill. leaves from Cameroon,” BMC Complementary and Alternative Medicine, vol. 13, article 130, 2013. View at Publisher · View at Google Scholar
  79. S. S. Biju, A. Ahuja, R. K. Khar, and R. Chaudhry, “Formulation and evaluation of an effective pH balanced topical antimicrobial product containing tea tree oil,” Pharmazie, vol. 60, no. 3, pp. 208–211, 2005. View at Google Scholar · View at Scopus
  80. S. Prabuseenivasan, M. Jayakumar, and S. Ignacimuthu, “In vitro antibacterial activity of some plant essential oils,” BMC Complementary and Alternative Medicine, vol. 6, article 39, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Tohidpour, M. Sattari, R. Omidbaigi, A. Yadegar, and J. Nazemi, “Antibacterial effect of essential oils from two medicinal plants against Methicillin-resistant Staphylococcus aureus (MRSA),” Phytomedicine, vol. 17, no. 2, pp. 142–145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. V. H. Tam, A. N. Schilling, and M. Nikolaou, “Modelling time-kill studies to discern the pharmacodynamics of meropenem,” Journal of Antimicrobial Chemotherapy, vol. 55, no. 5, pp. 699–706, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Burt, “Essential oils: their antibacterial properties and potential applications in foods—a review,” International Journal of Food Microbiology, vol. 94, no. 3, pp. 223–253, 2004. View at Publisher · View at Google Scholar · View at Scopus
  84. F. de Oliveira Pereira, P. A. Wanderley, F. A. C. Viana, R. B. de Lima, F. B. de Sousa, and E. de Oliveira Lima, “Growth inhibition and morphological alterations of Trichophyton rubrum induced by essential oil from Cymbopogon winterianus Jowitt ex Bor,” Brazilian Journal of Microbiology, vol. 42, no. 1, pp. 233–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. K. Kon and M. Rai, “Antibacterial activity of Thymus vulgaris essential oil alone and in combination with other essential oils,” Nusantara Bioscience, vol. 4, no. 2, pp. 50–56, 2012. View at Publisher · View at Google Scholar
  86. L. Cherrat, L. Espina, M. Bakkali, D. García-Gonzalo, R. Pagán, and A. Laglaoui, “Chemical composition and antioxidant properties of Laurus nobilis L. and Myrtus communis L. essential oils from Morocco and evaluation of their antimicrobial activity acting alone or in combined processes for food preservation,” Journal of the Science of Food and Agriculture, vol. 94, no. 6, pp. 1197–1204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. F. Sela, M. Karapandzova, G. Stefkov, I. Cvetkovikj, and S. Kulevanova, “Chemical composition and antimicrobial activity of essential oils of Juniperus excelsa Bieb. (Cupressaceae) grown in R. Macedonia,” Pharmacognosy Research, vol. 7, no. 1, pp. 74–80, 2015. View at Publisher · View at Google Scholar · View at Scopus
  88. P. A. Wayne, “Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard,” CLSI Document M38-A2, vol. 22, no. 16, 2008. View at Google Scholar
  89. M. Cuenca-Estrella, C. B. Moore, F. Barchiesi et al., “Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST),” Clinical Microbiology and Infection, vol. 9, no. 6, pp. 467–474, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. S. Messager, K. A. Hammer, C. F. Carson, and T. V. Riley, “Effectiveness of hand-cleansing formulations containing tea tree oil assessed ex vivo on human skin and in vivo with volunteers using European standard EN 1499,” The Journal of Hospital Infection, vol. 59, no. 3, pp. 220–228, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. M. D. Soković, J. Vukojević, P. D. Marin, D. D. Brkić, V. Vajs, and L. J. L. D. Van Griensven, “Chemical composition of essential oils of Thymus and Mentha species and their antifungal activities,” Molecules, vol. 14, no. 1, pp. 238–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  92. C. F. Carson and T. V. Riley, “Susceptibility of Propionibacterium acnes to the essential oil of Melaleuca alternifolia,” Letters in Applied Microbiology, vol. 19, no. 1, pp. 24–25, 1994. View at Publisher · View at Google Scholar · View at Scopus
  93. J. N. Eloff, “A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria,” Planta Medica, vol. 64, no. 8, pp. 711–713, 1998. View at Publisher · View at Google Scholar · View at Scopus
  94. C. König, H.-P. Simmen, and J. Blaser, “Reply (to Morrissey and George, 1999),” Journal of Antimicrobial Chemotherapy, vol. 43, no. 3, p. 425, 1999. View at Publisher · View at Google Scholar
  95. I. Morrissey, J. T. George, C. Konig, H.-P. Simmen, and J. Blaser, “The effect of the inoculum size on bactericidal activity,” Journal of Antimicrobial Chemotherapy, vol. 43, no. 3, pp. 423–425, 1999. View at Publisher · View at Google Scholar · View at Scopus
  96. R. J. W. Lambert, “Susceptibility testing: Inoculum size dependency of inhibition using the Colworth MIC technique,” Journal of Applied Microbiology, vol. 89, no. 2, pp. 275–279, 2000. View at Publisher · View at Google Scholar · View at Scopus
  97. M. D'Arrigo, G. Ginestra, G. Mandalari, P. M. Furneri, and G. Bisignano, “Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli,” Phytomedicine, vol. 17, no. 5, pp. 317–322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. E. L. de Souza, J. C. de Barros, C. E. V. de Oliveira, and M. L. da Conceição, “Influence of Origanum vulgare L. essential oil on enterotoxin production, membrane permeability and surface characteristics of Staphylococcus aureus,” International Journal of Food Microbiology, vol. 137, no. 2-3, pp. 308–311, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. S. de Rapper, G. Kamatou, A. Viljoen, and S. van Vuuren, “The in vitro antimicrobial activity of Lavandula angustifolia essential oil in combination with other aroma-therapeutic oils,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 852049, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Remmal, T. Bouchikhi, K. Rhayour, M. Ettayebi, and A. Tantaoui-Elaraki, “Improved method for the determination of antimicrobial activity of essential oils in agar medium,” Journal of Essential Oil Research, vol. 5, no. 2, pp. 179–184, 1993. View at Google Scholar · View at Scopus
  101. A. Pulido Pérez, O. Baniandrés Rodríguez, M. C. Ceballos Rodríguez, M. D. Mendoza Cembranos, M. Campos Domínguez, and R. Suárez Fernández, “Skin infections caused by community-acquired methicillin-resistant Staphylococcus aureus: clinical and microbiological characteristics of 11 cases,” Actas Dermo-Sifiliograficas, vol. 105, no. 2, pp. 150–158, 2014. View at Publisher · View at Google Scholar · View at Scopus
  102. S.-S. Kim, J. S. Baik, T.-H. Oh, W.-J. Yoon, N. H. Lee, and C.-G. Hyun, “Biological activities of Korean Citrus obovoides and Citrus natsudaidai essential oils against acne-inducing bacteria,” Bioscience, Biotechnology and Biochemistry, vol. 72, no. 10, pp. 2507–2513, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. P. J. Rennie, D. B. Gower, K. T. Holland, A. I. Mallet, and W. J. Watkins, “The skin microflora and the formation of human axillary odour,” International Journal of Cosmetic Science, vol. 12, no. 5, pp. 197–207, 1990. View at Publisher · View at Google Scholar · View at Scopus
  104. L. L. Barton and A. D. Friedman, “Impetigo: a reassessment of etiology and therapy,” Pediatric Dermatology, vol. 4, no. 3, pp. 185–188, 1987. View at Publisher · View at Google Scholar · View at Scopus
  105. L. B. Pereira, “Impetigo—review,” Anais Brasileiros de Dermatologia, vol. 89, no. 2, pp. 293–299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. D. L. Stevens, A. L. Bisno, H. F. Chambers et al., “Practice guidelines for the diagnosis and management of skin and soft-tissue infections,” Clinical Infectious Diseases, vol. 41, no. 10, pp. 1373–1406, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. L. G. Miller, F. Perdreau-Remington, G. Rieg et al., “Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles,” The New England Journal of Medicine, vol. 352, no. 14, pp. 1445–1453, 2005. View at Publisher · View at Google Scholar · View at Scopus
  108. W. W. J. Van de Sande, A. H. Fahal, T. V. Riley, H. Verbrugh, and A. van Belkum, “In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 3, pp. 553–555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. S. Wananukul, A. Chindamporn, P. Yumyourn, S. Payungporn, C. Samathi, and Y. Poovorawan, “Malassezia furfur in infantile seborrheic dermatitis,” Asian Pacific Journal of Allergy and Immunology, vol. 23, no. 2-3, pp. 101–105, 2005. View at Google Scholar · View at Scopus
  110. A. K. Gupta and K. A. Nicol, “Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis,” International Journal of Dermatology, vol. 45, no. 1, pp. 66–69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  111. J.-H. Lee and S.-K. Hong, “Comparative analysis of chemical compositions and antimicrobial activities of Essential oils from Abies holophylla and Abies koreana,” Journal of Microbiology and Biotechnology, vol. 19, no. 4, pp. 372–377, 2009. View at Publisher · View at Google Scholar · View at Scopus
  112. F. Candan, M. Unlu, B. Tepe et al., “Antioxidant and antimicrobial activity of the essential oil and methanol extracts of Achillea millefolium subsp. millefolium Afan. (Asteraceae),” Journal of Ethnopharmacology, vol. 87, no. 2-3, pp. 215–220, 2003. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Ünlü, D. Daferera, E. Dönmez, M. Polissiou, B. Tepe, and A. Sökmen, “Compositions and the in vitro antimicrobial activities of the essential oils of Achillea setacea and Achillea teretifolia (Compositae),” Journal of Ethnopharmacology, vol. 83, no. 1-2, pp. 117–121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  114. K. H. Hüsnü, B. Demirci, G. Iscan et al., “The essential oil constituents and antimicrobial activity of Anthemis aciphylla BOISS. var. discoidea BOISS,” Chemical and Pharmaceutical Bulletin, vol. 54, no. 2, pp. 222–225, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. A. J. Hayes and B. Markovic, “Toxicity of Australian essential oil Backhousia citriodora (Lemon myrtle). Part 1. Antimicrobial activity and in vitro cytotoxicity,” Food and Chemical Toxicology, vol. 40, no. 4, pp. 535–543, 2002. View at Publisher · View at Google Scholar · View at Scopus
  116. S. F. van Vuuren, G. P. P. Kamatou, and A. M. Viljoen, “Volatile composition and antimicrobial activity of twenty commercial frankincense essential oil samples,” South African Journal of Botany, vol. 76, no. 4, pp. 686–691, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. S. de Rapper, S. F. van Vuuren, G. P. P. Kamatou, A. M. Viljoen, and E. Dagne, “The additive and synergistic antimicrobial effects of select frankincense and myrrh oils-a combination from the pharaonic pharmacopoeia,” Letters in Applied Microbiology, vol. 54, no. 4, pp. 352–358, 2012. View at Publisher · View at Google Scholar · View at Scopus
  118. N. Tarek, H. M. Hassan, S. M. AbdelGhani, I. Radwan, O. Hammouda, and A. O. El-Gendy, “Comparative chemical and antimicrobial study of nine essential oils obtained from medicinal plants growing in Egypt,” Beni-Suef University Journal of Basic and Applied Sciences, vol. 3, no. 2, pp. 149–156, 2014. View at Publisher · View at Google Scholar
  119. L. N. Barbosa, I. da Silva Probst, B. F. M. T. Andrade et al., “In vitro antibacterial and chemical properties of essential oils including native plants from Brazil against pathogenic and resistant bacteria,” Journal of Oleo Science, vol. 64, no. 3, pp. 289–298, 2015. View at Publisher · View at Google Scholar
  120. A. B. Hsouna, N. Hamdi, N. B. Halima, and S. Abdelkafi, “Characterization of essential oil from Citrus aurantium L. flowers: antimicrobial and antioxidant activities,” Journal of Oleo Science, vol. 62, no. 10, pp. 763–772, 2013. View at Publisher · View at Google Scholar · View at Scopus
  121. T. Yangui, M. Bouaziz, A. Dhouib, and S. Sayadi, “Potential use of Tunisian Pituranthos chloranthus essential oils as a natural disinfectant,” Letters in Applied Microbiology, vol. 48, no. 1, pp. 112–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  122. A. Bag and R. R. Chattopadhyay, “Evaluation of synergistic antibacterial and antioxidant efficacy of essential oils of spices and herbs in combination,” PLoS ONE, vol. 10, no. 7, article e131321, 2015. View at Publisher · View at Google Scholar · View at Scopus
  123. I. Chéraif, H. Ben Jannet, M. Hammami, M. L. Khouja, and Z. Mighri, “Chemical composition and antimicrobial activity of essential oils of Cupressus arizonica Greene,” Biochemical Systematics and Ecology, vol. 35, no. 12, pp. 813–820, 2007. View at Publisher · View at Google Scholar · View at Scopus
  124. I. H. N. Bassolé, A. Lamien-Meda, B. Bayala et al., “Chemical composition and antimicrobial activity of Cymbopogon citratus and Cymbopogon giganteus essential oils alone and in combination,” Phytomedicine, vol. 18, no. 12, pp. 1070–1074, 2011. View at Publisher · View at Google Scholar · View at Scopus
  125. S. Pattnaik, V. R. Subramanyam, and C. R. Kole, “Antibacterial and antifungal activity of ten essential oils in vitro,” Microbios, vol. 86, no. 349, pp. 237–246, 1996. View at Google Scholar · View at Scopus
  126. S. Pattnaik, V. R. Subramanyam, M. Bapaji, and C. R. Kole, “Antibacterial and antifungal activity of aromatic constituents of essential oils,” Microbios, vol. 89, no. 358, pp. 39–46, 1997. View at Google Scholar · View at Scopus
  127. Y. Panahi, M. Sattari, A. P. Babaie et al., “The essential oils activity of Eucalyptus polycarpa, E. largiflorence, E. malliodora and E. camaldulensis on Staphylococcus aureus,” Iranian Journal of Pharmaceutical Research, vol. 10, no. 1, pp. 43–48, 2011. View at Google Scholar · View at Scopus
  128. R. Hamoud, F. Sporer, J. Reichling, and M. Wink, “Antimicrobial activity of a traditionally used complex essential oil distillate (Olbas® Tropfen) in comparison to its individual essential oil ingredients,” Phytomedicine, vol. 19, no. 11, pp. 969–976, 2012. View at Publisher · View at Google Scholar · View at Scopus
  129. V. Patrone, R. Campana, E. Vittoria, and W. Baffone, “In vitro synergistic activities of essential oils and surfactants in combination with cosmetic preservatives against Pseudomonas aeruginosa and Staphylococcus aureus,” Current Microbiology, vol. 60, no. 4, pp. 237–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. G. D. Mahumane, S. F. van Vuuren, G. Kamatou, M. Sandasi, and A. M. Viljoen, “Chemical composition and antimicrobial activity of Eucalyptus radiata leaf essential oil, sampled over a year,” Journal of Essential Oil Research, vol. 28, no. 6, pp. 475–488, 2016. View at Publisher · View at Google Scholar
  131. J. Safaei-Ghomi and A. Ahd, “Antimicrobial and antifungal properties of the essential oil and methanol extracts of Eucalyptus largiflorens andEucalyptus intertexta,” Pharmacognosy Magazine, vol. 6, no. 23, pp. 172–175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. W.-R. Diao, Q.-P. Hu, H. Zhang, and J.-G. Xu, “Chemical composition, antibacterial activity and mechanism of action of essential oil from seeds of fennel (Foeniculum vulgare Mill.),” Food Control, vol. 35, no. 1, pp. 109–116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  133. A. S. Mota, M. Rosário Martins, V. R. Lopes et al., “Antimicrobial activity and chemical composition of the essential oils of Portuguese Foeniculum vulgare fruits,” Natural Product Communications, vol. 10, no. 4, pp. 673–676, 2015. View at Google Scholar · View at Scopus
  134. F. Senatore, F. Oliviero, E. Scandolera et al., “Chemical composition, antimicrobial and antioxidant activities of anethole-rich oil from leaves of selected varieties of fennel [Foeniculum vulgare Mill. ssp. vulgare var. azoricum (Mill.) Thell],” Fitoterapia, vol. 90, pp. 214–219, 2013. View at Publisher · View at Google Scholar · View at Scopus
  135. S. Pepeljnjak, I. Kosalec, Z. Kalodera, and N. Blažević, “Antimicrobial activity of juniper berry essential oil (Juniperus communis L., Cupressaceae),” Acta Pharmaceutica, vol. 55, no. 4, pp. 417–422, 2005. View at Google Scholar · View at Scopus
  136. R. R. S. Nelson, “In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium,” Journal of Antimicrobial Chemotherapy, vol. 40, no. 2, pp. 305–306, 1997. View at Publisher · View at Google Scholar · View at Scopus
  137. F. Christoph, P.-M. Kaulfers, and E. Stahl-Biskup, “A comparative study of the in vitro antimicrobial activity of tea tree oils s.I. with special reference to the activity of β-triketones,” Planta Medica, vol. 66, no. 6, pp. 556–560, 2000. View at Publisher · View at Google Scholar · View at Scopus
  138. S. F. van Vuuren, Y. Docrat, G. P. P. Kamatou, and A. M. Viljoen, “Essential oil composition and antimicrobial interactions of understudied tea tree species,” South African Journal of Botany, vol. 92, pp. 7–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  139. A. I. Hussain, F. Anwar, P. S. Nigam et al., “Antibacterial activity of some Lamiaceae essential oils using resazurin as an indicator of cell growth,” LWT—Food Science and Technology, vol. 44, no. 4, pp. 1199–1206, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. S. F. Van Vuuren and A. M. Viljoen, “A comparative investigation of the antimicrobial properties of indigenous South African aromatic plants with popular commercially available essential oils,” Journal of Essential Oil Research, vol. 18, pp. 66–71, 2006. View at Google Scholar · View at Scopus
  141. R. A. Mothana, M. S. Alsaid, S. S. Hasoon, N. M. Al-Mosaiyb, A. J. Al-Rehaily, and M. A. Al-Yahya, “Antimicrobial and antioxidant activities and gas chromatography mass spectrometry (GC/MS) analysis of the essential oils of Ajuga bracteosa Wall. ex Benth. and Lavandula dentata L. growing wild in Yemen,” Journal of Medicinal Plants Research, vol. 6, no. 15, pp. 3066–3071, 2012. View at Google Scholar
  142. L. Cherrat, L. Espina, M. Bakkali, R. Pagán, and A. Laglaoui, “Chemical composition, antioxidant and antimicrobial properties of Mentha pulegium, Lavandula stoechas and Satureja calamintha Scheele essential oils and an evaluation of their bactericidal effect in combined processes,” Innovative Food Science and Emerging Technologies, vol. 22, pp. 221–229, 2014. View at Publisher · View at Google Scholar · View at Scopus
  143. S. Jian-Yu, L. Zhu, and Y.-J. Tian, “Chemical composition and antimicrobial activities of essential: oil of Matricaria songarica,” International Journal of Agriculture and Biology, vol. 14, no. 1, pp. 107–110, 2012. View at Google Scholar · View at Scopus
  144. K. L. LaPlante, “In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus,” Diagnostic Microbiology and Infectious Disease, vol. 57, no. 4, pp. 413–418, 2007. View at Publisher · View at Google Scholar · View at Scopus
  145. W. L. Low, C. Martin, D. J. Hill, and M. A. Kenward, “Antimicrobial efficacy of silver ions in combination with tea tree oil against Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans,” International Journal of Antimicrobial Agents, vol. 37, no. 2, pp. 162–165, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. M. A. S. McMahon, M. M. Tunney, J. E. Moore, I. S. Blair, D. F. Gilpin, and D. A. McDowell, “Changes in antibiotic susceptibility in staphylococci habituated to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia),” Letters in Applied Microbiology, vol. 47, no. 4, pp. 263–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  147. C. F. Carson, K. A. Hammer, and T. V. Riley, “Broth micro-dilution method for determining the susceptibility of Escherichia coli and Staphylococcus aureus to the essential oil of Melaleuca alternifolia (tea tree oil),” Microbios, vol. 82, no. 332, pp. 181–185, 1995. View at Google Scholar · View at Scopus
  148. C. F. Carson, B. D. Cookson, H. D. Farrelly, and T. V. Riley, “Susceptibility of methicillin-resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia,” Journal of Antimicrobial Chemotherapy, vol. 35, no. 3, pp. 421–424, 1995. View at Publisher · View at Google Scholar · View at Scopus
  149. S. D. Cox, C. M. Mann, J. L. Markham et al., “The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree oil),” Journal of Applied Microbiology, vol. 88, no. 1, pp. 170–175, 2000. View at Publisher · View at Google Scholar · View at Scopus
  150. S. D. Cox, C. M. Mann, and J. L. Markham, “Interactions between components of the essential oil of Melaleuca alternifolia,” Journal of Applied Microbiology, vol. 91, no. 3, pp. 492–497, 2001. View at Publisher · View at Google Scholar · View at Scopus
  151. G. K. F. Elsom and D. Hide, “Susceptibility of methicillin-resistant Staphylococcus aureus to tea tree oil and mupirocin,” Journal of Antimicrobial Chemotherapy, vol. 43, no. 3, pp. 427–428, 1999. View at Publisher · View at Google Scholar · View at Scopus
  152. K. A. Hammer, C. F. Carson, and T. V. Riley, “Susceptibility of transient and commensal skin flora to the essential oil of Melaleuca alternifolia (tea tree oil),” American Journal of Infection Control, vol. 24, no. 3, pp. 186–189, 1996. View at Publisher · View at Google Scholar · View at Scopus
  153. S. P. P. Falci, M. A. Teixeira, P. F. das Chagas et al., “Antimicrobial activity of Melaleuca sp. oil against clinical isolates of antibiotics resistant Staphylococcus aureus,” Acta Cirurgica Brasileira, vol. 30, no. 6, pp. 401–406, 2015. View at Publisher · View at Google Scholar · View at Scopus
  154. A. Raman, U. Weir, and S. F. Bloomfield, “Antimicrobial effects of tea tree oil and its major components on Staphylococcus aureus, Staphylococcus epidermidis and Propionibacterium acnes,” Letters in Applied Microbiology, vol. 21, no. 4, pp. 242–245, 1995. View at Publisher · View at Google Scholar · View at Scopus
  155. G. Işcan, N. Kirimer, M. Kürkcüoglu, K. H. C. Başer, and F. Demirci, “Antimicrobial screening of Mentha piperita essential oils,” Journal of Agricultural and Food Chemistry, vol. 50, no. 14, pp. 3943–3946, 2002. View at Publisher · View at Google Scholar · View at Scopus
  156. I. H. N. Bassolé, A. Lamien-Meda, B. Bayala et al., “Composition and antimicrobial activities of lippia multiflora Moldenke, Mentha x piperita L. and Ocimum basilicum L. essential oils and their major monoterpene alcohols alone and in combination,” Molecules, vol. 15, no. 11, pp. 7825–7839, 2010. View at Publisher · View at Google Scholar · View at Scopus
  157. A. Rosato, C. Vitali, N. De Laurentis, D. Armenise, and M. Antonietta Milillo, “Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin,” Phytomedicine, vol. 14, no. 11, pp. 727–732, 2007. View at Publisher · View at Google Scholar · View at Scopus
  158. G. Opalchenova and D. Obreshkova, “Comparative studies on the activity of basil-an essential oil from Ocimum basilicum L.-against multidrug resistant clinical isolates of the genera Staphylococcus, Enterococcus and Pseudomonas by using different test methods,” Journal of Microbiological Methods, vol. 54, no. 1, pp. 105–110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  159. M. T. Shirazi, H. Gholami, G. Kavoosi, V. Rowshan, and A. Tafsiry, “Chemical composition, antioxidant, antimicrobial and cytotoxic activities of Tagetes minuta and Ocimum basilicum essential oils,” Food Science and Nutrition, vol. 2, no. 2, pp. 146–155, 2014. View at Publisher · View at Google Scholar
  160. D. Beatović, D. Krstić-Milošević, S. Trifunović et al., “Chemical composition, antioxidant and antimicrobial activities of the essential oils of twelve Ocimum basilicum L. cultivars grown in Serbia,” Records of Natural Products, vol. 9, no. 1, pp. 62–75, 2015. View at Google Scholar
  161. M. Sökmen, J. Serkedjieva, D. Daferera et al., “In vitro antioxidant, antimicrobial, and antiviral activities of the essential oil and various extracts from herbal parts and callus cultures of Origanum acutidens,” Journal of Agricultural and Food Chemistry, vol. 52, no. 11, pp. 3309–3312, 2004. View at Publisher · View at Google Scholar · View at Scopus
  162. N. Aligiannis, E. Kalpoutzakis, S. Mitaku, and I. B. Chinou, “Composition and antimicrobial activity of the essential oils of two Origanum species,” Journal of Agricultural and Food Chemistry, vol. 49, no. 9, pp. 4168–4170, 2001. View at Publisher · View at Google Scholar · View at Scopus
  163. A. Nostro, A. R. Blanco, M. A. Cannatelli et al., “Susceptibility of methicillin-resistant Staphylococci to oregano essential oil, carvacrol and thymol,” FEMS Microbiology Letters, vol. 230, no. 2, pp. 191–195, 2004. View at Publisher · View at Google Scholar · View at Scopus
  164. R. J. W. Lambert, P. N. Skandamis, P. J. Coote, and G.-J. E. Nychas, “A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol,” Journal of Applied Microbiology, vol. 91, no. 3, pp. 453–462, 2001. View at Publisher · View at Google Scholar · View at Scopus
  165. C. Sarikurkcu, G. Zengin, M. Oskay, S. Uysal, R. Ceylan, and A. Aktumsek, “Composition, antioxidant, antimicrobial and enzyme inhibition activities of two Origanum vulgare subspecies (subsp. vulgare and subsp. hirtum) essential oils,” Industrial Crops and Products, vol. 70, pp. 178–184, 2015. View at Publisher · View at Google Scholar · View at Scopus
  166. M. Sienkiewicz, K. Poznańska-Kurowska, A. Kaszuba, and E. Kowalczyk, “The antibacterial activity of geranium oil against Gram-negative bacteria isolated from difficult-to-heal wounds,” Burns, vol. 40, no. 5, pp. 1046–1051, 2014. View at Publisher · View at Google Scholar · View at Scopus
  167. M. Mahboubi and N. Kazempour, “The antimicrobial activity of essential oil from Perovskia abrotanoides karel and its main components,” Indian Journal of Pharmaceutical Sciences, vol. 71, no. 3, pp. 343–347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  168. F. A. Al-Bayati, “Synergistic antibacterial activity between Thymus vulgaris and Pimpinella anisum essential oils and methanol extracts,” Journal of Ethnopharmacology, vol. 116, no. 3, pp. 403–406, 2008. View at Publisher · View at Google Scholar · View at Scopus
  169. Y. Fu, Y. Zu, L. Chen et al., “Antimicrobial activity of clove and rosemary essential oils alone and in combination,” Phytotherapy Research, vol. 21, no. 10, pp. 989–994, 2007. View at Publisher · View at Google Scholar · View at Scopus
  170. Y. Jiang, N. Wu, Y.-J. Fu et al., “Chemical composition and antimicrobial activity of the essential oil of Rosemary,” Environmental Toxicology and Pharmacology, vol. 32, no. 1, pp. 63–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  171. S. Luqman, G. R. Dwivedi, M. P. Darokar, A. Kalra, and S. P. S. Khanuja, “Potential of Rosemary oil to be used in drug-resistant infections,” Alternative Therapies in Health and Medicine, vol. 13, no. 5, pp. 54–59, 2007. View at Google Scholar · View at Scopus
  172. O. O. Okoh, A. P. Sadimenko, and A. J. Afolayan, “Comparative evaluation of the antibacterial activities of the essential oils of Rosmarinus officinalis L. obtained by hydrodistillation and solvent free microwave extraction methods,” Food Chemistry, vol. 120, no. 1, pp. 308–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  173. V. Cardile, A. Russo, C. Formisano et al., “Essential oils of Salvia bracteata and Salvia rubifolia from Lebanon: chemical composition, antimicrobial activity and inhibitory effect on human melanoma cells,” Journal of Ethnopharmacology, vol. 126, no. 2, pp. 265–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  174. A. H. Ebrahimabadi, A. Mazoochi, F. J. Kashi, Z. Djafari-Bidgoli, and H. Batooli, “Essential oil composition and antioxidant and antimicrobial properties of the aerial parts of Salvia eremophila Boiss. from Iran,” Food and Chemical Toxicology, vol. 48, no. 5, pp. 1371–1376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  175. K. Vagionas, O. Ngassapa, D. Runyoro, K. Graikou, O. Gortzi, and I. Chinou, “Chemical analysis of edible aromatic plants growing in Tanzania,” Food Chemistry, vol. 105, no. 4, pp. 1711–1717, 2007. View at Publisher · View at Google Scholar · View at Scopus
  176. N. Adrar, N. Oukil, and F. Bedjou, “Antioxidant and antibacterial activities of Thymus numidicus and Salvia officinalis essential oils alone or in combination,” Industrial Crops and Products, vol. 88, pp. 112–119, 2016. View at Publisher · View at Google Scholar · View at Scopus
  177. O. Tzakou, D. Pitarokili, I. B. Chinou, and C. Harvala, “Composition and antimicrobial activity of the essential oil of Salvia ringens,” Planta Medica, vol. 67, no. 1, pp. 81–83, 2001. View at Publisher · View at Google Scholar · View at Scopus
  178. G. Özek, F. Demirci, T. Özek et al., “Gas chromatographic-mass spectrometric analysis of volatiles obtained by four different techniques from Salvia rosifolia Sm., and evaluation for biological activity,” Journal of Chromatography A, vol. 1217, no. 5, pp. 741–748, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. M. Sienkiewicz, A. Głowacka, K. Poznańska-Kurowska, A. Kaszuba, A. Urbaniak, and E. Kowalczyk, “The effect of clary sage oil on Staphylococci responsible for wound infections,” Advances in Dermatology and Allergology, vol. 32, no. 1, pp. 21–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  180. M. Ünlü, G. Vardar-Ünlü, N. Vural, E. Dönmez, and Z. Y. Özbaş, “Chemical composition, antibacterial and antifungal activity of the essential oil of Thymbra spicata L. from Turkey,” Natural Product Research, vol. 23, no. 6, pp. 572–579, 2009. View at Publisher · View at Google Scholar · View at Scopus
  181. S. Cosentino, C. I. G. Tuberoso, B. Pisano et al., “In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils,” Letters in Applied Microbiology, vol. 29, no. 2, pp. 130–135, 1999. View at Publisher · View at Google Scholar · View at Scopus
  182. M. Sienkiewicz, M. Łysakowska, P. Denys, and E. Kowalczyk, “The antimicrobial activity of thyme essential oil against multidrug resistant clinical bacterial strains,” Microbial Drug Resistance, vol. 18, no. 2, pp. 137–148, 2012. View at Publisher · View at Google Scholar · View at Scopus
  183. D. S. Alviano and C. S. Alviano, “Plant extracts: search for new alternatives to treat microbial diseases,” Current Pharmaceutical Biotechnology, vol. 10, no. 1, pp. 106–121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  184. F. Nazzaro, F. Fratianni, L. De Martino, R. Coppola, and V. De Feo, “Effect of essential oils on pathogenic bacteria,” Pharmaceuticals, vol. 6, no. 12, pp. 1451–1474, 2013. View at Publisher · View at Google Scholar · View at Scopus
  185. S. Nishijima, I. Kurokawa, N. Katoh, and K. Watanabe, “The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium aches and Staphylococcus epidermidis isolated from acne lesions,” The Journal of Dermatology, vol. 27, no. 5, pp. 318–323, 2000. View at Publisher · View at Google Scholar · View at Scopus
  186. M. Guggenheim, R. Zbinden, A. E. Handschin, A. Gohritz, M. A. Altintas, and P. Giovanoli, “Changes in bacterial isolates from burn wounds and their antibiograms: a 20-year study (1986–2005),” Burns, vol. 35, no. 4, pp. 553–560, 2009. View at Publisher · View at Google Scholar · View at Scopus
  187. F. Solórzano-Santos and M. G. Miranda-Novales, “Essential oils from aromatic herbs as antimicrobial agents,” Current Opinion in Biotechnology, vol. 23, no. 2, pp. 136–141, 2012. View at Publisher · View at Google Scholar · View at Scopus
  188. F. Espersen, “Resistance to antibiotics used in dermatological practice,” The British Journal of Dermatology, vol. 139, no. 53, pp. 4–8, 1998. View at Publisher · View at Google Scholar · View at Scopus
  189. M. Caelli, J. Porteous, C. F. Carson, R. Heller, and T. V. Riley, “Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus,” The Journal of Hospital Infection, vol. 46, no. 3, pp. 236–237, 2000. View at Publisher · View at Google Scholar · View at Scopus
  190. CDC, Antibiotic Resistance Threats in the United States, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2013.
  191. B. D. Cookson, “The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice,” Journal of Antimicrobial Chemotherapy, vol. 41, no. 1, pp. 11–18, 1998. View at Publisher · View at Google Scholar · View at Scopus
  192. H. W. Boucher, G. H. Talbot, J. S. Bradley et al., “Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of America,” Clinical Infectious Diseases, vol. 48, no. 1, pp. 1–12, 2009. View at Publisher · View at Google Scholar · View at Scopus
  193. P. H. Warnke, E. Sherry, P. A. J. Russo et al., “Antibacterial essential oils in malodorous cancer patients: clinical observations in 30 patients,” Phytomedicine, vol. 13, no. 7, pp. 463–467, 2006. View at Publisher · View at Google Scholar · View at Scopus
  194. V. Edwards-Jones, R. Buck, S. G. Shawcross, M. M. Dawson, and K. Dunn, “The effect of essential oils on methicillin-resistant Staphylococcus aureus using a dressing model,” Burns, vol. 30, no. 8, pp. 772–777, 2004. View at Publisher · View at Google Scholar · View at Scopus
  195. D. Ames, “Aromatic wound care in a health care system: a report from the United States,” International Journal of Clinical Aromatherapy, vol. 3, no. 2, pp. 3–8, 2006. View at Google Scholar
  196. R. L. P. Lee, P. H. M. Leung, and T. K. S. Wong, “A randomized controlled trial of topical tea tree preparation for MRSA colonized wounds,” International Journal of Nursing Sciences, vol. 1, no. 1, pp. 7–14, 2014. View at Publisher · View at Google Scholar
  197. C. E. Detillion, T. K. S. Craft, E. R. Glasper, B. J. Prendergast, and A. C. DeVries, “Social facilitation of wound healing,” Psychoneuroendocrinology, vol. 29, no. 8, pp. 1004–1011, 2004. View at Publisher · View at Google Scholar · View at Scopus
  198. M. Vurnek, J. Weinman, C. Whiting, and J. Tarlton, “Skin immune markers: psychosocial determinants and the effect on wound healing,” Brain, Behavior, and Immunity, vol. 20, no. 3, pp. 73–74, 2006. View at Publisher · View at Google Scholar
  199. G. Thompson, B. Blackwood, R. McMullan et al., “A randomized controlled trial of tea tree oil (5%) body wash versus standard body wash to prevent colonization with methicillin-resistant Staphylococcus aureus (MRSA) in critically ill adults: research protocol,” BMC Infectious Diseases, vol. 8, no. 1, article 161, 2008. View at Publisher · View at Google Scholar · View at Scopus
  200. M. Dryden, S. Dailly, and M. Crouch, “A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization,” The Journal of Hospital Infection, vol. 56, no. 4, pp. 283–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  201. M. Edmondson, N. Newall, K. Carville, J. Smith, T. V. Riley, and C. F. Carson, “Uncontrolled, open-label, pilot study of tea tree (Melaleuca alternifolia) oil solution in the decolonisation of methicillin-resistant Staphylococcus aureus positive wounds and its influence on wound healing,” International Wound Journal, vol. 8, no. 4, pp. 375–384, 2011. View at Publisher · View at Google Scholar · View at Scopus
  202. K. B. Chin and B. Cordell, “The effect of tea tree oil (Melaleuca alternifolia) on wound healing using a dressing model,” Journal of Alternative and Complementary Medicine, vol. 19, no. 12, pp. 942–945, 2013. View at Publisher · View at Google Scholar · View at Scopus
  203. B. Blackwood, G. Thompson, R. Mcmullan et al., “Tea tree oil (5%) body wash versus standard care (johnson's baby softwash) to prevent colonization with methicillin-resistant Staphylococcus aureus in critically ill adults: a randomized controlled trial,” Journal of Antimicrobial Chemotherapy, vol. 68, no. 5, pp. 1193–1199, 2013. View at Publisher · View at Google Scholar · View at Scopus
  204. M. Gebrehiwot, K. Asres, D. Bisrat, A. Mazumder, P. Lindemann, and F. Bucar, “Evaluation of the wound healing property of Commiphora guidottii Chiov. ex. Guid,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, pp. 282–292, 2015. View at Publisher · View at Google Scholar · View at Scopus
  205. L. O. Orafidiya, E. O. Agbani, O. A. Abereoje, T. Awe, A. Abudu, and F. A. Fakoya, “An investigation into the wound-healing properties of essential oil of Ocimum gratissimum linn,” Journal of Wound Care, vol. 12, no. 9, pp. 331–334, 2003. View at Publisher · View at Google Scholar · View at Scopus
  206. N. S. Scheinfeld, “Acne: a review of diagnosis and treatment,” Pharmacy and Therapeutics, vol. 32, no. 6, pp. 340–347, 2007. View at Google Scholar · View at Scopus
  207. T. H. Oh, S.-S. Kim, W.-J. Yoon et al., “Chemical composition and biological activities of Jeju Thymus quinquecostatus essential oils against Propionibacterium species inducing acne,” Journal of General and Applied Microbiology, vol. 55, no. 1, pp. 63–68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  208. W.-J. Yoon, S.-S. Kim, T.-H. Oh, N. H. Lee, and C.-G. Hyun, “Abies koreana essential oil inhibits drug-resistant skin pathogen growth and lps-induced inflammatory effects of murine macrophage,” Lipids, vol. 44, no. 5, pp. 471–476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  209. Y. Zu, H. Yu, L. Liang et al., “Activities of ten essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 cancer cells,” Molecules, vol. 15, no. 5, pp. 3200–3210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  210. S. Luangnarumitchai, S. Lamlertthon, and W. Tiyaboonchai, “Antimicrobial activity of essential oils against five strains of Propionibacterium acnes,” Mahidol University Journal of Pharmaceutical Sciences, vol. 34, no. 1–4, pp. 60–64, 2007. View at Google Scholar
  211. T. Nuryastuti, H. C. Van Der Mei, H. J. Busscher, S. Iravati, A. T. Aman, and B. P. Krom, “Effect of cinnamon oil on icaA expression and biofilm formation by Staphylococcus epidermidis,” Applied and Environmental Microbiology, vol. 75, no. 21, pp. 6850–6855, 2009. View at Publisher · View at Google Scholar · View at Scopus
  212. J. S. Baik, S. S. Kim, J. A. Lee et al., “Chemical composition and biological activities of essential oils extracted from Korean endemic citrus species,” Journal of Microbiology and Biotechnology, vol. 18, no. 1, pp. 74–79, 2008. View at Google Scholar
  213. T. J. Karpanen, T. Worthington, E. R. Hendry, B. R. Conway, and P. A. Lambert, “Antimicrobial efficacy of chlorhexidine digluconate alone and in combination with eucalyptus oil, tea tree oil and thymol against planktonic and biofilm cultures of Staphylococcus epidermidis,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 5, pp. 1031–1036, 2008. View at Publisher · View at Google Scholar · View at Scopus
  214. S. Athikomkulchai, R. Watthanachaiyingcharoen, S. Tunvichien et al., “The development of anti-acne products from Eucalyptus globulus and Psidium guajava oil,” Journal of Health Research, vol. 22, no. 3, pp. 109–113, 2008. View at Google Scholar
  215. E. Gavini, V. Sanna, R. Sharma et al., “Solid lipid microparticles (SLM) containing Juniper oil as anti-acne topical carriers: preliminary studies,” Pharmaceutical Development and Technology, vol. 10, no. 4, pp. 479–487, 2005. View at Publisher · View at Google Scholar · View at Scopus
  216. Y. Fu, L. Chen, Y. Zu et al., “The antibacterial activity of clove essential oil against Propionibacterium acnes and its mechanism of action,” Archives of Dermatology, vol. 145, no. 1, pp. 86–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  217. L. O. Orafidiya, E. O. Agbani, A. O. Oyedele, O. O. Babalola, and O. Onayemi, “Preliminary clinical tests on topical preparations of Ocimum gratissimum linn leaf essential oil for the treatment of acne vulgaris,” Clinical Drug Investigation, vol. 22, no. 5, pp. 313–319, 2002. View at Publisher · View at Google Scholar · View at Scopus
  218. I. B. Bassett, D. L. Pannowitz, and R. S. C. Barnetson, “A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne,” Medical Journal of Australia, vol. 153, no. 8, pp. 455–458, 1990. View at Google Scholar · View at Scopus
  219. S. Enshaieh, A. Jooya, A. H. Siadat, and F. Iraji, “The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study,” Indian Journal of Dermatology, Venereology and Leprology, vol. 73, no. 1, pp. 22–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  220. G. Matiz, M. R. Osorio, F. Camacho, M. Atencia, and J. Herazo, “Effectiveness of antimicrobial formulations for acne based on orange (Citrus sinensis) and sweet basil (Ocimum basilicum L) essential oils,” Biomedica, vol. 32, no. 1, pp. 125–133, 2012. View at Google Scholar
  221. M. Vaara, “Agents that increase the permeability of the outer membrane,” Microbiological Reviews, vol. 56, no. 3, pp. 395–411, 1992. View at Google Scholar · View at Scopus
  222. S. G. Griffin, S. G. Wyllie, and J. L. Markham, “Role of the outer membrane of Eschericia coli AG100 and Pseudomonas aeruginosa NCTC 6749 and resistance/susceptibility to monoterpenes of similar chemical structure,” Journal of Essential Oil Research, vol. 13, no. 5, pp. 380–386, 2001. View at Publisher · View at Google Scholar · View at Scopus
  223. M. Sienkiewicz, M. Łysakowska, M. Pastuszka, W. Bienias, and E. Kowalczyk, “The potential of use basil and rosemary essential oils as effective antibacterial agents,” Molecules, vol. 18, no. 8, pp. 9334–9351, 2013. View at Publisher · View at Google Scholar · View at Scopus
  224. C. Velasco, L. Romero, J. M. R. Martínez, J. Rodríguez-Baño, and A. Pascual, “Analysis of plasmids encoding extended-spectrum β-lactamases (ESBLs) from Escherichia coli isolated from non-hospitalised patients in Seville,” International Journal of Antimicrobial Agents, vol. 29, no. 1, pp. 89–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  225. D. C. Wu, W. W. Chan, A. I. Metelitsa, L. Fiorillo, and A. N. Lin, “Pseudomonas skin infection: clinical features, epidemiology, and management,” American Journal of Clinical Dermatology, vol. 12, no. 3, pp. 157–169, 2011. View at Publisher · View at Google Scholar · View at Scopus
  226. S. G. Deans and G. Ritchie, “Antibacterial properties of plant essential oils,” International Journal of Food Microbiology, vol. 5, no. 2, pp. 165–180, 1987. View at Publisher · View at Google Scholar · View at Scopus
  227. R. Piccaglia, M. Marotti, E. Giovanelli, S. G. Deans, and E. Eaglesham, “Antibacterial and antioxidant properties of Mediterranean aromatic plants,” Industrial Crops and Products, vol. 2, no. 1, pp. 47–50, 1993. View at Publisher · View at Google Scholar · View at Scopus
  228. H. J. D. Dorman and S. G. Deans, “Antimicrobial agents from plants: antibacterial activity of plant volatile oils,” Journal of Applied Microbiology, vol. 88, no. 2, pp. 308–316, 2000. View at Publisher · View at Google Scholar · View at Scopus
  229. S. Ozturk and S. Ercisli, “Antibacterial activity and chemical constitutions of Ziziphora clinopodioides,” Food Control, vol. 18, no. 5, pp. 535–540, 2007. View at Publisher · View at Google Scholar · View at Scopus
  230. A. Maxia, D. Falconieri, A. Piras et al., “Chemical composition and antifungal activity of essential oils and supercritical CO2 extracts of Apium nodiflorum (L.) Lag,” Mycopathologia, vol. 174, no. 1, pp. 61–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  231. R. Becerril, C. Nerín, and R. Gómez-Lus, “Evaluation of bacterial resistance to essential oils and antibiotics after exposure to oregano and cinnamon essential oils,” Foodborne Pathogens and Disease, vol. 9, no. 8, pp. 699–705, 2012. View at Publisher · View at Google Scholar · View at Scopus
  232. M. Nasir, K. Tafess, and D. Abate, “Antimicrobial potential of the Ethiopian Thymus schimperi essential oil in comparison with others against certain fungal and bacterial species,” BMC Complementary and Alternative Medicine, vol. 15, no. 1, article 260, 2015. View at Publisher · View at Google Scholar · View at Scopus
  233. C. C. Rath, S. Devi, S. K. Dash, and R. K. Mishra, “Antibacterial potential assessment of Jasmine essential oil against E. coli,” Indian Journal of Pharmaceutical Sciences, vol. 70, no. 2, pp. 238–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  234. C. J. Papadopoulos, C. F. Carson, K. A. Hammer, and T. V. Riley, “Susceptibility of Pseudomonads to Melaleuca alternifolia (tea tree) oil and components,” Journal of Antimicrobial Chemotherapy, vol. 58, no. 2, pp. 449–451, 2006. View at Publisher · View at Google Scholar · View at Scopus
  235. C. F. Carson, K. A. Hammer, and T. V. Riley, “In-vitro activity of the essential oil of Melaleuca alternifolia against Streptococcus spp.,” Journal of Antimicrobial Chemotherapy, vol. 37, no. 6, pp. 1177–1178, 1996. View at Publisher · View at Google Scholar · View at Scopus
  236. K. A. Hammer, C. F. Carson, and T. V. Riley, “In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp,” Journal of Antimicrobial Chemotherapy, vol. 42, no. 5, pp. 591–595, 1998. View at Publisher · View at Google Scholar · View at Scopus
  237. A. N. Devkatte, G. B. Zore, and S. M. Karuppayil, “Potential of plant oils as inhibitors of Candida albicans growth,” FEMS Yeast Research, vol. 5, no. 9, pp. 867–873, 2005. View at Publisher · View at Google Scholar · View at Scopus
  238. R. Giordani, P. Regli, J. Kaloustian, and H. Portugal, “Potentiation of antifungal activity of amphotericin B by essential oil from Cinnamomum cassia,” Phytotherapy Research, vol. 20, no. 1, pp. 58–61, 2006. View at Publisher · View at Google Scholar · View at Scopus
  239. M. Białoń, T. Krzyśko-Łupicka, M. Koszałkowska, and P. P. Wieczorek, “The influence of chemical composition of commercial lemon essential oils on the growth of Candida strains,” Mycopathologia, vol. 177, no. 1-2, pp. 29–39, 2014. View at Publisher · View at Google Scholar · View at Scopus
  240. V. F. Furletti, I. P. Teixeira, G. Obando-Pereda et al., “Action of Coriandrum sativum L. essential oil upon oral Candida albicans biofilm formation,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 985832, 9 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  241. A. C. Tavares, M. J. Gonçalves, C. Cavaleiro et al., “Essential oil of Daucus carota subsp. halophilus: composition, antifungal activity and cytotoxicity,” Journal of Ethnopharmacology, vol. 119, no. 1, pp. 129–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  242. A. Maxia, B. Marongiu, A. Piras et al., “Chemical characterization and biological activity of essential oils from Daucus carota L. subsp. carota growing wild on the Mediterranean coast and on the Atlantic coast,” Fitoterapia, vol. 80, no. 1, pp. 57–61, 2009. View at Publisher · View at Google Scholar · View at Scopus
  243. C. Cavaleiro, E. Pinto, M. J. Gonçalves, and L. Salgueiro, “Antifungal activity of Juniperus essential oils against dermatophyte, Aspergillus and Candida strains,” Journal of Applied Microbiology, vol. 100, no. 6, pp. 1333–1338, 2006. View at Publisher · View at Google Scholar · View at Scopus
  244. C. Cabral, V. Francisco, C. Cavaleiro et al., “Essential oil of Juniperus communis subsp. alpina (Suter) Čelak needles: chemical composition, antifungal activity and cytotoxicity,” Phytotherapy Research, vol. 26, no. 9, pp. 1352–1357, 2012. View at Publisher · View at Google Scholar · View at Scopus
  245. M. Zuzarte, M. J. Gonçalves, C. Cavaleiro, A. M. Dinis, J. M. Canhoto, and L. R. Salgueiro, “Chemical composition and antifungal activity of the essential oils of Lavandula pedunculata (MILLER) CAV.,” Chemistry and Biodiversity, vol. 6, no. 8, pp. 1283–1292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  246. M. Zuzarte, M. J. Gonçalves, C. Cavaleiro et al., “Antifungal and anti-inflammatory potential of Lavandula stoechas and Thymus herba-barona essential oils,” Industrial Crops and Products, vol. 44, pp. 97–103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  247. M. Zuzarte, M. J. Gonçalves, C. Cavaleiro et al., “Chemical composition and antifungal activity of the essential oils of Lavandula viridis l'her,” Journal of Medical Microbiology, vol. 60, no. 5, pp. 612–618, 2011. View at Publisher · View at Google Scholar · View at Scopus
  248. F. Mondello, F. De Bernardis, A. Girolamo, G. Salvatore, and A. Cassone, “In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts,” Journal of Antimicrobial Chemotherapy, vol. 51, no. 5, pp. 1223–1229, 2003. View at Publisher · View at Google Scholar · View at Scopus
  249. A. Rosato, C. Vitali, M. Piarulli, M. Mazzotta, M. P. Argentieri, and R. Mallamaci, “In vitro synergic efficacy of the combination of Nystatin with the essential oils of Origanum vulgareand Pelargonium graveolens against some Candida species,” Phytomedicine, vol. 16, no. 10, pp. 972–975, 2009. View at Publisher · View at Google Scholar · View at Scopus
  250. M. Mahboubi and G. Haghi, “Antimicrobial activity and chemical composition of Mentha pulegium L. essential oil,” Journal of Ethnopharmacology, vol. 119, no. 2, pp. 325–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  251. A. Bouzabata, O. Bazzali, C. Cabral et al., “New compounds, chemical composition, antifungal activity and cytotoxicity of the essential oil from Myrtus nivellei Batt. & Trab., an endemic species of Central Sahara,” Journal of Ethnopharmacology, vol. 149, no. 3, pp. 613–620, 2013. View at Publisher · View at Google Scholar · View at Scopus
  252. P. R. N. Vieira, S. M. de Morais, F. H. Q. Bezerra, P. A. T. Ferreira, I. R. Oliveira, and M. G. V. Silva, “Chemical composition and antifungal activity of essential oils from Ocimum species,” Industrial Crops and Products, vol. 55, pp. 267–271, 2014. View at Publisher · View at Google Scholar
  253. B. Bozin, N. Mimica-Dukic, N. Simin, and G. Anackov, “Characterization of the volatile composition of essential oils of some lamiaceae spices and the antimicrobial and antioxidant activities of the entire oils,” Journal of Agricultural and Food Chemistry, vol. 54, no. 5, pp. 1822–1828, 2006. View at Publisher · View at Google Scholar · View at Scopus
  254. C. V. Nakamura, K. Ishida, L. C. Faccin et al., “In vitro activity of essential oil from Ocimum gratissimum L. against four Candida species,” Research in Microbiology, vol. 155, no. 7, pp. 579–586, 2004. View at Publisher · View at Google Scholar · View at Scopus
  255. K. Amber, A. Aijaz, X. Immaculata, K. A. Luqman, and M. Nikhat, “Anticandidal effect of Ocimum sanctum essential oil and its synergy with fluconazole and ketoconazole,” Phytomedicine, vol. 17, no. 12, pp. 921–925, 2010. View at Publisher · View at Google Scholar · View at Scopus
  256. I. Kosalec, S. Pepeljnjak, and D. Kuatrak, “Antifungal activity of fluid extract and essential oil from anise fruits (Pimpinella anisum L., Apiaceae),” Acta Pharmaceutica, vol. 55, no. 4, pp. 377–385, 2005. View at Google Scholar · View at Scopus
  257. Y. Hristova, V. Gochev, J. Wanner, L. Jirovetz, E. Schmidt, and T. Girova, “Chemical composition and antifungal activity of essential oil of Salvia sclarea L. from Bulgaria against clinical isolates of Candida species,” Journal of Bioscience and Biotechnology, vol. 2, no. 1, pp. 39–44, 2013. View at Google Scholar
  258. E. Pinto, L. Vale-Silva, C. Cavaleiro, and L. Salgueiro, “Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species,” Journal of Medical Microbiology, vol. 58, part 11, pp. 1454–1462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  259. A. Saad, M. Fadli, M. Bouaziz, A. Benharref, N.-E. Mezrioui, and L. Hassani, “Anticandidal activity of the essential oils of Thymus maroccanus and Thymus broussonetii and their synergism with amphotericin B and fluconazol,” Phytomedicine, vol. 17, no. 13, pp. 1057–1060, 2010. View at Publisher · View at Google Scholar · View at Scopus
  260. S. Shin and J.-H. Kim, “Antifungal activities of essential oils from Thymus quinquecostatus and T. magnus,” Planta Medica, vol. 70, no. 11, pp. 1090–1092, 2004. View at Publisher · View at Google Scholar · View at Scopus
  261. C. Pina-Vaz, A. G. Rodrigues, E. Pinto et al., “Antifungal activity of Thymus oils and their major compounds,” Journal of the European Academy of Dermatology and Venereology, vol. 18, no. 1, pp. 73–78, 2004. View at Publisher · View at Google Scholar · View at Scopus
  262. L. A. Vale-Silva, M. J. Gonçalves, C. Cavaleiro, L. Salgueiro, and E. Pinto, “Antifungal activity of the essential oil of Thymus x viciosoi against Candida, Cryptococcus, Aspergillus and dermatophyte species,” Planta Medica, vol. 76, no. 9, pp. 882–888, 2010. View at Publisher · View at Google Scholar · View at Scopus
  263. M. J. Gonçalves, M. T. Cruz, C. Cavaleiro, M. C. Lopes, and L. Salgueiro, “Chemical, antifungal and cytotoxic evaluation of the essential oil of Thymus zygis subsp. sylvestris,” Industrial Crops and Products, vol. 32, no. 1, pp. 70–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  264. S. Shin and S. Lim, “Antifungal effects of herbal essential oils alone and in combination with ketoconazole against Trichophyton spp,” Journal of Applied Microbiology, vol. 97, no. 6, pp. 1289–1296, 2004. View at Publisher · View at Google Scholar · View at Scopus
  265. M. Sanguinetti, B. Posteraro, L. Romano et al., “In vitro activity of Citrus bergamia (bergamot) oil against clinical isolates of dermatophytes,” Journal of Antimicrobial Chemotherapy, vol. 59, no. 2, pp. 305–308, 2007. View at Publisher · View at Google Scholar · View at Scopus
  266. L. Mugnaini, S. Nardoni, L. Pinto et al., “In vitro and in vivo antifungal activity of some essential oils against feline isolates of Microsporum canis,” Journal de Mycologie Médicale, vol. 22, no. 2, pp. 179–184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  267. E. B. Baptista, D. C. Zimmermann-Franco, A. A. B. Lataliza, and N. R. B. Raposo, “Chemical composition and antifungal activity of essential oil from Eucalyptus smithii against dermatophytes,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 48, no. 6, pp. 746–752, 2015. View at Publisher · View at Google Scholar · View at Scopus
  268. K. A. Hammer, C. F. Carson, and T. V. Riley, “In vitro activities of ketoconazole, econazole, miconazole, and Melaleuca alternifolia (tea tree) oil against Malassezia species,” Antimicrobial Agents and Chemotherapy, vol. 44, no. 2, pp. 467–469, 2000. View at Publisher · View at Google Scholar · View at Scopus
  269. A. R. Khosravi, H. Shokri, and S. Fahimirad, “Efficacy of medicinal essential oils against pathogenic Malassezia sp. isolates,” Journal of Medical Mycology, vol. 26, no. 1, pp. 28–34, 2016. View at Publisher · View at Google Scholar
  270. M. R. R. Silva, J. G. Oliveira Jr., O. F. L. Fernandes et al., “Antifungal activity of Ocimum gratissimum towards dermatophytes,” Mycoses, vol. 48, no. 3, pp. 172–175, 2005. View at Publisher · View at Google Scholar · View at Scopus
  271. M. S. A. Khan, I. Ahmad, and S. S. Cameotra, “Carum copticum and Thymus vulgaris oils inhibit virulence in Trichophyton rubrum and Aspergillus spp,” Brazilian Journal of Microbiology, vol. 45, no. 2, pp. 523–531, 2014. View at Publisher · View at Google Scholar · View at Scopus
  272. F. Behmanesh, H. Pasha, A. A. Sefidgar et al., “Antifungal effect of lavender essential oil (Lavandula angustifolia) and clotrimazole on Candida albicans: an in vitro study,” Scientifica, vol. 2015, Article ID 261397, 5 pages, 2015. View at Publisher · View at Google Scholar
  273. J. A. Woodfolk, “Allergy and dermatophytes,” Clinical Microbiology Reviews, vol. 18, no. 1, pp. 30–43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  274. J. D. Croxtall and G. L. Plosker, “Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology,” Drugs, vol. 69, no. 3, pp. 339–359, 2009. View at Publisher · View at Google Scholar · View at Scopus
  275. A. C. Satchell, A. Saurajen, C. Bell, and R. S. Barnetson, “Treatment of dandruff with 5% tea tree oil shampoo,” Journal of the American Academy of Dermatology, vol. 47, no. 6, pp. 852–855, 2002. View at Publisher · View at Google Scholar · View at Scopus
  276. A. K. Gupta, K. Nicol, and R. Batra, “Role of antifungal agents in the treatment of seborrheic dermatitis,” American Journal of Clinical Dermatology, vol. 5, no. 6, pp. 417–422, 2004. View at Publisher · View at Google Scholar · View at Scopus
  277. I. Weitzman and R. C. Summerbell, “The dermatophytes,” Clinical Microbiology Reviews, vol. 8, no. 2, pp. 240–259, 1995. View at Google Scholar · View at Scopus
  278. C. F. Carson, K. A. Hammer, and T. V. Riley, “Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties,” Clinical Microbiology Reviews, vol. 19, no. 1, pp. 50–62, 2006. View at Publisher · View at Google Scholar · View at Scopus
  279. D. S. Buck, D. M. Nidorf, and J. G. Addino, “Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole,” Journal of Family Practice, vol. 38, no. 6, pp. 601–605, 1994. View at Google Scholar · View at Scopus
  280. K. A. Hammer, C. F. Carson, and T. V. Riley, “In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi,” Journal of Antimicrobial Chemotherapy, vol. 50, no. 2, pp. 195–199, 2002. View at Publisher · View at Google Scholar · View at Scopus
  281. M. M. Tong, P. M. Altman, and R. S. Barnetson, “Tea tree oil in the treatment of tinea pedis,” Australasian Journal of Dermatology, vol. 33, no. 3, pp. 145–149, 1992. View at Publisher · View at Google Scholar · View at Scopus
  282. A. C. Satchell, A. Saurajen, C. Bell, and R. S. C. Barnetson, “Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study,” The Australasian Journal of Dermatology, vol. 43, no. 3, pp. 175–178, 2002. View at Publisher · View at Google Scholar · View at Scopus
  283. P. H. Warnke, S. T. Becker, R. Podschun et al., “The battle against multi-resistant strains: renaissance of antimicrobial essential oils as a promising force to fight hospital-acquired infections,” Journal of Cranio-Maxillofacial Surgery, vol. 37, no. 7, pp. 392–397, 2009. View at Publisher · View at Google Scholar · View at Scopus
  284. T. J. Karpanen, B. R. Conway, T. Worthington, A. C. Hilton, T. S. J. Elliott, and P. A. Lambert, “Enhanced chlorhexidine skin penetration with eucalyptus oil,” BMC Infectious Diseases, vol. 10, article 278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  285. T. A. Syed, Z. A. Qureshi, S. M. Ali, S. Ahmad, and S. A. Ahmad, “Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream,” Tropical Medicine and International Health, vol. 4, no. 4, pp. 284–287, 1999. View at Publisher · View at Google Scholar · View at Scopus
  286. J. Bensouilah and P. Buck, Aromadermatology: Aromatherapy in the Treatment and Care of Common Skin Conditions, Radcliffe Publishing, Abingdon, UK, 2006.
  287. H. Wagner, “Multitarget therapy—the future of treatment for more than just functional dyspepsia,” Phytomedicine, vol. 13, supplement 1, pp. 122–129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  288. H. Wagner and G. Ulrich-Merzenich, “Synergy research: approaching a new generation of phytopharmaceuticals,” Phytomedicine, vol. 16, no. 2-3, pp. 97–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  289. S. Suliman, S. F. van Vuuren, and A. M. Viljoen, “Validating the in vitro antimicrobial activity of Artemisia afra in polyherbal combinations to treat respiratory infections,” South African Journal of Botany, vol. 76, no. 4, pp. 655–661, 2010. View at Publisher · View at Google Scholar
  290. G. Cottarel and J. Wierzbowski, “Combination drugs, an emerging option for antibacterial therapy,” Trends in Biotechnology, vol. 25, no. 12, pp. 547–555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  291. R. C. Li, J. J. Schentag, and D. E. Nix, “The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions,” Antimicrobial Agents and Chemotherapy, vol. 37, no. 3, pp. 523–531, 1993. View at Publisher · View at Google Scholar · View at Scopus
  292. T. Inui, Y. Wang, S. Deng, D. C. Smith, S. G. Franzblau, and G. F. Pauli, “Counter-current chromatography based analysis of synergy in an anti-tuberculosis ethnobotanical,” Journal of Chromatography A, vol. 1151, no. 1-2, pp. 211–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  293. J. Blazquez, M.-R. Baquero, R. Canton, I. Alos, and F. Baquero, “Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli,” Antimicrobial Agents and Chemotherapy, vol. 37, no. 10, pp. 2059–2063, 1993. View at Publisher · View at Google Scholar · View at Scopus
  294. M. C. Enright, D. A. Robinson, G. Randle, E. J. Feil, H. Grundmann, and B. G. Spratt, “The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA),” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 11, pp. 7687–7692, 2002. View at Publisher · View at Google Scholar · View at Scopus
  295. S. Kapoor and S. Saraf, “Topical herbal therapies an alternative and complementary choice to combat acne,” Research Journal of Medicinal Plant, vol. 5, no. 6, pp. 650–669, 2011. View at Publisher · View at Google Scholar · View at Scopus
  296. J. Grassmann, S. Hippeli, K. Dornisch, U. Rohnert, N. Beuscher, and E. F. Elstner, “Antioxidant properties of essential oils: possible explanations for their anti-inflammatory effects,” Arzneimittel-Forschung, vol. 50, no. 2, pp. 135–139, 2000. View at Google Scholar · View at Scopus
  297. N. A. Trivedi and S. C. Hotchandani, “A study of the antimicrobial activity of oil of Eucalyptus,” Indian Journal of Pharmacology, vol. 36, no. 2, pp. 93–94, 2004. View at Google Scholar
  298. M. H. Boelens, “Chemical and sensory evaluation of lavandula oils,” Perfumer and Flavorist, vol. 20, no. 3, pp. 23–51, 1995. View at Google Scholar
  299. H. M. A. Cavanagh and J. M. Wilkinson, “Biological activities of lavender essential oil,” Phytotherapy Research, vol. 16, no. 4, pp. 301–308, 2002. View at Publisher · View at Google Scholar · View at Scopus
  300. N. Pazyar, R. Yaghoobi, N. Bagherani, and A. Kazerouni, “A review of applications of tea tree oil in dermatology,” International Journal of Dermatology, vol. 52, no. 7, pp. 784–790, 2013. View at Publisher · View at Google Scholar · View at Scopus
  301. M. Karaca, H. Özbek, A. Him, M. Tütüncü, H. A. Akkan, and V. Kaplanoglu, “Investigation of anti-inflammatory activity of bergamot oil,” European Journal of General Medicine, vol. 4, no. 4, pp. 176–179, 2007. View at Google Scholar · View at Scopus
  302. P. Forlot and P. Pevet, “Bergamot (Citrus bergamia Risso et Poiteau) essential oil: biological properties, cosmetic and medical use. A review,” Journal of Essential Oil Research, vol. 24, no. 2, pp. 195–201, 2012. View at Publisher · View at Google Scholar · View at Scopus
  303. S. Cassella, J. P. Cassella, and I. Smith, “Synergistic antifungal activity of tea tree (Melaleuca alternifolia) and lavender (Lavandula angustifolia) essential oils against dermatophyte infection,” International Journal of Aromatherapy, vol. 12, no. 1, pp. 2–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  304. S. F. Van Vuuren, S. Suliman, and A. M. Viljoen, “The antimicrobial activity of four commercial essential oils in combination with conventional antimicrobials,” Letters in Applied Microbiology, vol. 48, no. 4, pp. 440–446, 2009. View at Publisher · View at Google Scholar · View at Scopus
  305. A. N. Boucher and V. H. Tam, “Mathematical formulation of additivity for antimicrobial agents,” Diagnostic Microbiology and Infectious Disease, vol. 55, no. 4, pp. 319–325, 2006. View at Publisher · View at Google Scholar · View at Scopus
  306. M. C. Berenbaum, “A method for testing for synergy with any number of agents,” Journal of Infectious Diseases, vol. 137, no. 2, pp. 122–130, 1978. View at Publisher · View at Google Scholar · View at Scopus
  307. R. J. W. Lambert and R. Lambert, “A model for the efficacy of combined inhibitors,” Journal of Applied Microbiology, vol. 95, no. 4, pp. 734–743, 2003. View at Publisher · View at Google Scholar · View at Scopus
  308. E. M. Williamson, “Synergy and other interactions in phytomedicines,” Phytomedicine, vol. 8, no. 5, pp. 401–409, 2001. View at Publisher · View at Google Scholar · View at Scopus
  309. A. Bell, “Antimalarial drug synergism and antagonism: mechanistic and clinical significance,” FEMS Microbiology Letters, vol. 253, no. 2, pp. 171–184, 2005. View at Publisher · View at Google Scholar · View at Scopus
  310. R. J. Tallarida, “An overview of drug combination analysis with isobolograms,” The Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 1, pp. 1–7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  311. D. Wing-Shing Cheung, C.-M. Koon, C.-F. Ng et al., “The roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibit atherogenic events: a study of the combination effects of the 2-herb formula,” Journal of Ethnopharmacology, vol. 143, no. 3, pp. 859–866, 2012. View at Publisher · View at Google Scholar · View at Scopus
  312. R. Lewis, R. Guha, T. Korcsmaros, and A. Bender, “Synergy Maps: exploring compound combinations using network-based visualization,” Journal of Cheminformatics, vol. 7, article 36, 2015. View at Publisher · View at Google Scholar · View at Scopus
  313. P. Goñi, P. López, C. Sánchez, R. Gómez-Lus, R. Becerril, and C. Nerín, “Antimicrobial activity in the vapour phase of a combination of cinnamon and clove essential oils,” Food Chemistry, vol. 116, no. 4, pp. 982–989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  314. J. Gutierrez, C. Barry-Ryan, and P. Bourke, “The antimicrobial efficacy of plant essential oil combinations and interactions with food ingredients,” International Journal of Food Microbiology, vol. 124, no. 1, pp. 91–97, 2008. View at Publisher · View at Google Scholar · View at Scopus
  315. V. G. Honório, J. Bezerra, G. T. Souza et al., “Inhibition of Staphylococcus aureus cocktail using the synergies of oregano and rosemary essential oils or carvacrol and 1,8-cineole,” Frontiers in Microbiology, vol. 6, article 1223, 2015. View at Publisher · View at Google Scholar · View at Scopus
  316. A. K. Geda, “Antibacterial activity of essential oils and their combination,” Fat Science and Technology, vol. 97, no. 12, pp. 458–460, 1995. View at Publisher · View at Google Scholar
  317. D. Hartman and J. C. Coetzee, “Two US practitioners' experience of using essential oils for wound care,” Journal of Wound Care, vol. 11, no. 8, pp. 317–320, 2002. View at Publisher · View at Google Scholar · View at Scopus
  318. R. Guba, “Wound healing,” International Journal of Aromatherapy, vol. 9, no. 2, pp. 67–74, 1999. View at Publisher · View at Google Scholar · View at Scopus
  319. S. Shin and C.-A. Kang, “Antifungal activity of the essential oil of Agastache rugosa Kuntze and its synergism with ketoconazole,” Letters in Applied Microbiology, vol. 36, no. 2, pp. 111–115, 2003. View at Publisher · View at Google Scholar · View at Scopus
  320. V. Lorenzi, A. Muselli, A. F. Bernardini et al., “Geraniol restores antibiotic activities against multidrug-resistant isolates from gram-negative species,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 5, pp. 2209–2211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  321. V. de Carvalho Nilo Bitu, H. D. T. F. Fecundo, H. D. M. Coutinho et al., “Chemical composition of the essential oil of Lippia gracilis Schauer leaves and its potential as modulator of bacterial resistance,” Natural Product Research, vol. 28, no. 6, pp. 399–402, 2014. View at Publisher · View at Google Scholar
  322. R. Harris, “Synergism in the essential oil world,” International Journal of Aromatherapy, vol. 12, no. 4, pp. 179–186, 2002. View at Publisher · View at Google Scholar · View at Scopus
  323. J.-M. Bolla, S. Alibert-Franco, J. Handzlik et al., “Strategies for bypassing the membrane barrier in multidrug resistant Gram-negative bacteria,” FEBS Letters, vol. 585, no. 11, pp. 1682–1690, 2011. View at Publisher · View at Google Scholar · View at Scopus
  324. H. Si, J. Hu, Z. Liu, and Z.-L. Zeng, “Antibacterial effect of oregano essential oil alone and in combination with antibiotics against extended-spectrum β-lactamase-producing Escherichia coli,” FEMS Immunology and Medical Microbiology, vol. 53, no. 2, pp. 190–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  325. A. C. Gradinaru, A. C. Aprotosoaie, A. Trifan, A. Spac, M. Brebu, and A. Miron, “Interaction between cardamom essential oil and conventional antibiotics against Staphylococcus aureus clinical isolates,” Farmacia, vol. 62, no. 6, pp. 1214–1222, 2014. View at Google Scholar
  326. R. Giordani, P. Regli, J. Kaloustian, C. Mikaïl, L. Abou, and H. Portugal, “Antifungal effect of various essential oils against Candida albicans. Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris,” Phytotherapy Research, vol. 18, no. 12, pp. 990–995, 2004. View at Publisher · View at Google Scholar · View at Scopus
  327. P. S. X. Yap, S. H. E. Lim, C. P. Hu, and B. C. Yiap, “Combination of essential oils and antibiotics reduce antibiotic resistance in plasmid-conferred multidrug resistant bacteria,” Phytomedicine, vol. 20, no. 8-9, pp. 710–713, 2013. View at Publisher · View at Google Scholar · View at Scopus
  328. Z. Schelz, J. Molnar, and J. Hohmann, “Antimicrobial and antiplasmid activities of essential oils,” Fitoterapia, vol. 77, no. 4, pp. 279–285, 2006. View at Publisher · View at Google Scholar · View at Scopus
  329. M. Fadli, A. Saad, S. Sayadi et al., “Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection-bacteria and their synergistic potential with antibiotics,” Phytomedicine, vol. 19, no. 5, pp. 464–471, 2012. View at Publisher · View at Google Scholar · View at Scopus
  330. T. Malik, P. Singh, S. Pant, N. Chauhan, and H. Lohani, “Potentiation of antimicrobial activity of ciprofloxacin by pelargonium graveolens essential oil against selected uropathogens,” Phytotherapy Research, vol. 25, no. 8, pp. 1225–1228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  331. M. Minami, M. Kita, T. Nakaya, T. Yamamoto, H. Kuriyama, and J. Imanishi, “The inhibitory effect of essential oils on herpes simplex virus type-1 replication in vitro,” Microbiology and Immunology, vol. 47, no. 9, pp. 681–684, 2003. View at Publisher · View at Google Scholar · View at Scopus
  332. M. R. Loizzo, A. M. Saab, R. Tundis et al., “Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species,” Chemistry & Biodiversity, vol. 5, no. 3, pp. 461–470, 2008. View at Publisher · View at Google Scholar · View at Scopus
  333. S. Gavanji, S. S. Sayedipour, B. Larki, and A. Bakhtari, “Antiviral activity of some plant oils against herpes simplex virus type 1 in Vero cell culture,” Journal of Acute Medicine, vol. 5, no. 3, pp. 62–68, 2015. View at Publisher · View at Google Scholar · View at Scopus
  334. P. Schnitzler, K. Schön, and J. Reichling, “Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture,” Die Pharmazie, vol. 56, no. 4, pp. 343–347, 2001. View at Google Scholar · View at Scopus
  335. C. Koch, Antivirale effekte ausgewahlter atherischer Ole auf behullte Viren unter besonderer berucksichtiging des herpes simplex virus typ 1 und 2 [Dissertation], Universitat Heidelberg, 2005.
  336. C. Koch, J. Reichling, J. Schneele, and P. Schnitzler, “Inhibitory effect of essential oils against herpes simplex virus type 2,” Phytomedicine, vol. 15, no. 1-2, pp. 71–78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  337. P. Schnitzler, C. Koch, and J. Reichling, “Susceptibility of drug-resistant clinical herpes simplex virus type 1 strains to essential oils of ginger, thyme, hyssop, and sandalwood,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 5, pp. 1859–1862, 2007. View at Publisher · View at Google Scholar · View at Scopus
  338. C. Koch, J. Reichling, and P. Schnitzler, “Essential oils inhibit the replication of herpes simples virus type 1 (HSV-1) and type 2 (HSV-2),” in Botanical Medicine in Clinical Practice, V. R. Preedy and R. R. Watson, Eds., pp. 192–197, CABI, Wallingsford, UK, 2008. View at Google Scholar
  339. J. Reichling, C. Koch, E. Stahl-Biskup, C. Sojka, and P. Schnitzler, “Virucidal activity of a β-triketone-rich essential oil of Leptospermum scoparium (manuka oil) against HSV-1 and HSV-2 in cell culture,” Planta Medica, vol. 71, no. 12, pp. 1123–1127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  340. A. Garozzo, R. Timpanaro, B. Bisignano, P. M. Furneri, G. Bisignano, and A. Castro, “In vitro antiviral activity of Melaleuca alternifolia essential oil,” Letters in Applied Microbiology, vol. 49, no. 6, pp. 806–808, 2009. View at Publisher · View at Google Scholar · View at Scopus
  341. L. Civitelli, S. Panella, M. E. Marcocci et al., “In vitro inhibition of herpes simplex virus type 1 replication by Mentha suaveolens essential oil and its main component piperitenone oxide,” Phytomedicine, vol. 21, no. 6, pp. 857–865, 2014. View at Publisher · View at Google Scholar · View at Scopus
  342. P. Schnitzler, A. Schuhmacher, A. Astani, and J. Reichling, “Melissa officinalis oil affects infectivity of enveloped herpesviruses,” Phytomedicine, vol. 15, no. 9, pp. 734–740, 2008. View at Publisher · View at Google Scholar · View at Scopus
  343. A. Schuhmacher, J. Reichling, and P. Schnitzler, “Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro,” Phytomedicine, vol. 10, no. 6-7, pp. 504–510, 2003. View at Publisher · View at Google Scholar · View at Scopus
  344. F. Benencia and M. C. Courrèges, “Antiviral activity of sandalwood oil against Herpes simplex viruses-1 and -2,” Phytomedicine, vol. 6, no. 2, pp. 119–123, 1999. View at Publisher · View at Google Scholar · View at Scopus
  345. A. De Logu, G. Loy, M. L. Pellerano, L. Bonsignore, and M. L. Schivo, “Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil,” Antiviral Research, vol. 48, no. 3, pp. 177–185, 2000. View at Publisher · View at Google Scholar · View at Scopus
  346. M. Mahboubi and F. G. Bidgoli, “In vitro synergistic efficacy of combination of amphotericin B with Myrtus communis essential oil against clinical isolates of Candida albicans,” Phytomedicine, vol. 17, no. 10, pp. 771–774, 2010. View at Publisher · View at Google Scholar · View at Scopus
  347. M. Mahboubi and F. Ghazian Bidgoli, “Antistaphylococcal activity of Zataria multiflora essential oil and its synergy with vancomycin,” Phytomedicine, vol. 17, no. 7, pp. 548–550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  348. D. T. Bearden, G. P. Allen, and J. M. Christensen, “Comparative in vitro activities of topical wound care products against community-associated methicillin-resistant Staphylococcus aureus,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 4, pp. 769–772, 2008. View at Publisher · View at Google Scholar · View at Scopus
  349. C. F. Carson, L. Ashton, L. Dry, D. W. Smith, and T. V. Riley, “Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis,” Journal of Antimicrobial Chemotherapy, vol. 48, no. 3, pp. 450–451, 2001. View at Publisher · View at Google Scholar · View at Scopus
  350. B. C. Millar and J. E. Moore, “Successful topical treatment of hand warts in a paediatric patient with tea tree oil (Melaleuca alternifolia),” Complementary Therapies in Clinical Practice, vol. 14, no. 4, pp. 225–227, 2008. View at Publisher · View at Google Scholar · View at Scopus
  351. A. E. Edris, “Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review,” Phytotherapy Research, vol. 21, no. 4, pp. 308–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  352. D. Raines, “Wound care,” in Aromatherapy for Health Professionals, S. Price and L. Price, Eds., chapter 10, Churchill Livingstone, London, UK, 4th edition, 2012. View at Google Scholar
  353. S. M. Clark and S. M. Wilkinson, “Phototoxic contact dermatitis from 5-methoxypsoralen in aromatherapy oil,” Contact Dermatitis, vol. 38, no. 5, pp. 289–290, 1998. View at Publisher · View at Google Scholar · View at Scopus
  354. H. Cocks and D. Wilson, “Letter to the editor,” Burns, vol. 24, no. 1, p. 82, 1998. View at Google Scholar · View at Scopus
  355. S. Kaddu, H. Kerl, and P. Wolf, “Accidental bullous phototoxic reactions to bergamot aromatherapy oil,” Journal of the American Academy of Dermatology, vol. 45, no. 3, pp. 458–461, 2001. View at Publisher · View at Google Scholar · View at Scopus
  356. B. Nair, “Final report on the safety assessment of Mentha piperita (peppermint) oil, Mentha piperita (peppermint) leaf extract, Mentha piperita (peppermint) leaf, and Mentha piperita (peppermint) leaf water,” International Journal of Toxicology, vol. 20, pp. 61–73, 2001. View at Google Scholar
  357. A. Prashar, I. C. Locke, and C. S. Evans, “Cytotoxicity of lavender oil and its major components to human skin cells,” Cell Proliferation, vol. 37, no. 3, pp. 221–229, 2004. View at Publisher · View at Google Scholar · View at Scopus
  358. N. Bleasel, B. Tate, and M. Rademaker, “Allergic contact dermatitis following exposure to essential oils,” Australasian Journal of Dermatology, vol. 43, no. 3, pp. 211–213, 2002. View at Publisher · View at Google Scholar · View at Scopus
  359. A. Trattner, M. David, and A. Lazarov, “Occupational contact dermatitis due to essential oils,” Contact Dermatitis, vol. 58, no. 5, pp. 282–284, 2008. View at Publisher · View at Google Scholar · View at Scopus
  360. W. Boonchai, P. Iamtharachai, and P. Sunthonpalin, “Occupational allergic contact dermatitis from essential oils in aromatherapists,” Contact Dermatitis, vol. 56, no. 3, pp. 181–182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  361. A. Stonehouse and J. Studdiford, “Allergic contact dermatitis from tea tree oil,” Consultant, vol. 47, no. 8, p. 781, 2007. View at Google Scholar · View at Scopus
  362. N. Aspres and S. Freeman, “Predictive testing for irritancy and allergenicity of tea tree oil in normal human subjects,” Exogenous Dermatology, vol. 2, no. 5, pp. 258–261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  363. N. K. Veien, K. Rosner, and G. L. Skovgaard, “Is tea tree oil an important contact allergen?” Contact Dermatitis, vol. 50, no. 6, pp. 378–379, 2004. View at Publisher · View at Google Scholar · View at Scopus
  364. T. Rutherford, R. Nixon, M. Tam, and B. Tate, “Allergy to tea tree oil: retrospective review of 41 cases with positive patch tests over 4.5 years,” Australasian Journal of Dermatology, vol. 48, no. 2, pp. 83–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  365. C. Pirker, B. M. Hausen, W. Uter et al., “Sensitization to tea tree oil in Germany and Austria. A multicenter study of the German Contact Dermatitis Group,” Journal of the German Society of Dermatology, vol. 1, no. 8, pp. 629–634, 2003. View at Publisher · View at Google Scholar · View at Scopus
  366. M. K. Robinson, G. F. Gerberick, C. A. Ryan, P. McNamee, I. R. White, and D. A. Basketter, “The importance of exposure estimation in the assessment of skin sensitization risk,” Contact Dermatitis, vol. 42, no. 5, pp. 251–259, 2000. View at Publisher · View at Google Scholar · View at Scopus
  367. G. F. Gerberick, M. K. Robinson, S. P. Felter, I. R. White, and D. A. Basketter, “Understanding fragrance allergy using an exposure-based risk assessment approach,” Contact Dermatitis, vol. 45, no. 6, pp. 333–340, 2001. View at Publisher · View at Google Scholar · View at Scopus
  368. P. Van der Valk, A. De Groot, D. Bruynzeel, P. Coenraads, and J. Weijland, “Allergic contact eczema due to'tea tree'oil,” Nederlands Tijdschrift voor Geneeskunde, vol. 138, no. 16, pp. 823–825, 1994. View at Google Scholar
  369. N. B. Mozelsio, K. E. Harris, K. G. McGrath, and L. C. Grammer, “Immediate systemic hypersensitivity reaction associated with topical application of Australian tea tree oil,” Allergy and Asthma Proceedings, vol. 24, no. 1, pp. 73–75, 2003. View at Google Scholar · View at Scopus
  370. U. Lippert, A. Walter, B. Hausen, and T. Fuchs, “127 Increasing incidence of contact dermatitis to tea tree oil,” Journal of Allergy and Clinical Immunology, vol. 105, no. 1, p. S43, 2000. View at Publisher · View at Google Scholar
  371. M. Bhushan and M. H. Beck, “Allergic contact dermatitis from tea tree oil in a wart paint,” Contact Dermatitis, vol. 36, no. 2, pp. 117–118, 1997. View at Publisher · View at Google Scholar · View at Scopus
  372. E. Herro and S. E. Jacob, “Mentha piperita (Peppermint),” Dermatitis, vol. 21, no. 6, pp. 327–329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  373. N. Gemeda, K. Urga, A. Tadele, H. Lemma, D. Melaku, and K. Mudie, “Antimicrobial activity of topical formulation containing Eugenia caryophyllata L. (Krunfud) and Myritus communis L. (Ades) essential oils on selected skin disease causing microorganisms,” Ethiopian Journal of Health Sciences, vol. 18, no. 3, pp. 101–107, 2008. View at Google Scholar